US20210370068A1 - Floatable catheters for neuromodulation - Google Patents

Floatable catheters for neuromodulation Download PDF

Info

Publication number
US20210370068A1
US20210370068A1 US17/148,961 US202117148961A US2021370068A1 US 20210370068 A1 US20210370068 A1 US 20210370068A1 US 202117148961 A US202117148961 A US 202117148961A US 2021370068 A1 US2021370068 A1 US 2021370068A1
Authority
US
United States
Prior art keywords
catheter
elongate body
electrodes
pulmonary artery
electrode array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/148,961
Inventor
Steven L. Waldhauser
Steven D. Goedeke
Duane G. Frion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardionomic Inc
Original Assignee
Cardionomic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardionomic Inc filed Critical Cardionomic Inc
Priority to US17/148,961 priority Critical patent/US20210370068A1/en
Publication of US20210370068A1 publication Critical patent/US20210370068A1/en
Assigned to CARDIONOMIC, Inc. reassignment CARDIONOMIC, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FRION, DUANE G., GOEDEKE, STEVEN D., WALDHAUSER, STEVEN L.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36114Cardiac control, e.g. by vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M25/005Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0133Tip steering devices
    • A61M25/0147Tip steering devices with movable mechanical means, e.g. pull wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • A61N1/0558Anchoring or fixation means therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0587Epicardial electrode systems; Endocardial electrodes piercing the pericardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36132Control systems using patient feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M2025/018Catheters having a lateral opening for guiding elongated means lateral to the catheter

Definitions

  • the present disclosure relates generally to catheters, and more particularly to catheter and electrode systems for use in electrical neuromodulation.
  • Acute heart failure is a cardiac condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs.
  • the condition impairs quality of life and is a leading cause of hospitalizations and mortality in the western world.
  • Treating acute heart failure is typically aimed at removal of precipitating causes, prevention of deterioration in cardiac function, and control of the patient's congestive state.
  • Treatments for acute heart failure include the use of inotropic agents, such as dopamine and dobutamine. These agents, however, have both chronotropic and inotropic effects and characteristically increase heart contractility at the expense of significant increments in oxygen consumption secondary to elevations in heart rate. As a result, although these inotropic agents increase myocardial contractility and improve hemodynamics, clinical trials have consistently demonstrated excess mortality caused by cardiac arrhythmias and increase in the myocardium consumption.
  • Embodiments of the present disclosure provide for catheter and electrode systems for use in electrical neuromodulation.
  • the catheter and electrode systems of the present disclosure may be useful in electrical neuromodulation of patients with cardiac disease, such as patients with chronic cardiac disease.
  • the configuration of the catheter and electrode systems of the present disclosure allows for a portion of the catheter to be positioned within the vasculature of the patient in the main pulmonary artery and/or one or both of the pulmonary arteries (the right pulmonary artery and/or the left pulmonary artery). Once positioned, the catheter and electrode systems of the present disclosure can provide electrical energy to stimulate the autonomic nerve fibers surrounding the main pulmonary artery and/or one or both of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient.
  • the catheter of the present disclosure includes an elongate body having a first end and a second end.
  • the elongate body includes a longitudinal center axis that extends between the first end and the second end.
  • the elongate body further includes three or more surfaces that define a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis.
  • the catheter further includes one or more, but preferably two or more, electrodes on one surface of the three or more surfaces of the elongate body, where conductive elements extend through the elongate body.
  • the conductive elements can conduct electrical current to combinations of the one or more electrodes or in the instance of a single electrode a second electrode is provided elsewhere in the system for flow of current.
  • the surfaces defining the convex polygonal cross-sectional shape of the elongate body can be a rectangle. Other shapes are possible.
  • the one or two or more electrodes are only on the one surface of the three or more surfaces of the elongate body.
  • the one or more electrodes can have an exposed face that is co-planar with the one surface of the three or more surfaces of the elongate body.
  • the one surface of the three or more surfaces of the elongate body can further include anchor structures that extend above the one surface.
  • the elongate body of the catheter can also have a portion with a circular cross-section shape taken perpendicularly to the longitudinal center axis.
  • the catheter of the present embodiment can also include an inflatable balloon on a peripheral surface of the elongate body.
  • the inflatable balloon includes a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume.
  • An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon.
  • the catheter of the present disclosure includes an elongate body having a peripheral surface and a longitudinal center axis extending between a first end and a second end.
  • the elongate body of this second example has an offset region defined by a series of predefined curves along the longitudinal center axis.
  • the predefined curves include a first portion having a first curve and a second curve in the longitudinal center axis, a second portion following the first portion, where the second portion has a zero curvature (e.g., a straight portion), and a third portion following the second portion, the third portion having a third curve and a fourth curve.
  • An inflatable balloon is positioned on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume.
  • An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon.
  • One or more electrodes are positioned on the elongate body along the second portion of the offset region of the elongate body. Conductive elements extend through the elongate body, where the conductive elements conduct electrical current to combinations of the one or more electrodes.
  • the portions of the elongate body of this second example can have a variety of shapes.
  • the second portion of the elongate body can form a portion of a helix.
  • the elongate body can also have three or more surfaces defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis, where the one or more electrodes are on one surface of the three or more surfaces of the elongate body.
  • the convex polygonal cross-sectional shape can be a rectangle.
  • the one or more electrodes are only on the one surface of the three or more surfaces of the elongate body.
  • the one or more electrodes can have an exposed face that is co-planar with the one surface of the three or more surfaces of the elongate body.
  • the catheter of the present disclosure includes an elongate body with a peripheral surface and a longitudinal center axis extending between a first end and a second end.
  • the elongate body includes a surface defining a deflection lumen, where the deflection lumen includes a first opening and a second opening in the elongate body.
  • An inflatable balloon is located on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume.
  • An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon.
  • One or more electrodes are located on the elongate body, where the second opening of the deflection lumen is opposite the one or more electrodes on the elongate body.
  • Conductive elements extend through the elongate body, where the conductive elements conduct electrical current to combinations of the one or more electrodes.
  • the catheter also includes an elongate deflection member, where the elongate deflection member extends through the second opening of the deflection lumen in a direction opposite the one or more electrodes on one surface of the elongate body.
  • the catheter of the present disclosure can include an elongate body having a peripheral surface and a longitudinal center axis extending between a first end and a second end.
  • the elongate body includes a surface defining an electrode lumen, where the electrode lumen includes a first opening in the elongate body.
  • the catheter further includes an inflatable balloon on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume.
  • An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon.
  • the catheter further includes an elongate electrode member, where the elongate electrode member extends through the first opening of the electrode lumen of the elongate body, where the electrode member includes one or more electrodes and conductive elements extending through the electrode lumen, where the conductive elements conduct electrical current to combinations of the one or more electrodes.
  • the elongate electrode member can form a loop that extends away from the peripheral surface of the elongate body.
  • the elongate electrode member forming the loop can be in a plane that is co-linear with the longitudinal center axis of the elongate body.
  • the elongate electrode member forming the loop is in a plane that is perpendicular to the longitudinal center axis of the elongate body.
  • FIG. 1 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 2 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 3 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 4 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 5 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 6 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 7 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 8 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 9 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 10 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 11 provides an illustration of a main pulmonary artery of a heart.
  • FIG. 12 provides an illustration of a stimulation system for use with the catheter of the present system.
  • Embodiments of the present disclosure provide for a catheter and electrode systems for use in electrical neuromodulation.
  • the catheter and electrode systems of the present disclosure may be useful in electrical neuromodulation of patients with cardiac disease, such as patients with chronic cardiac disease.
  • the configuration of the catheter and electrode systems of the present disclosure allows for a portion of the catheter and electrode systems to be positioned within the vasculature of the patient in the main pulmonary artery and at least one of the pulmonary arteries (the right pulmonary artery and/or the left pulmonary artery). Once positioned, the catheter and electrode systems of the present disclosure can be used to provide electrical energy to stimulate the autonomic nerve fibers surrounding the main pulmonary artery and/or one of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient.
  • distal and proximal are used in the following description with respect to a position or direction relative to the treating clinician taken along the catheter of the present disclosure. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician taken along the catheter of the present disclosure.
  • the catheters and electrode systems provided herein includes one or more electrodes, but preferably two or more electrodes, as discussed herein. It is understood that the phrase one or more electrodes can be replaced herein with two or more electrodes if desired.
  • the catheter 100 includes an elongate body 102 having a first end 104 and a second end 106 distal from the first end 104 .
  • the elongate body 102 includes a longitudinal center axis 108 extending between the first end 104 and the second end 106 of the elongate body 102 .
  • the elongate body 102 also includes a portion 110 that has three or more surfaces 112 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 108 .
  • the convex polygonal cross-sectional shape of the elongate body 102 includes those shapes for which every internal angle is less than 180 degrees and where every line segment between two vertices of the shape remains inside or on the boundary of the shape. Examples of such shapes include, but are not limited to, triangular, rectangular (as illustrated in FIG. 1 ), square, pentagon and hexagon, among others.
  • Catheter 100 further includes one or more, preferably two or more, electrodes 114 on one surface of the three or more surfaces 112 of the elongate body 102 .
  • Conductive elements 116 extend through the elongate body 102 , where the conductive elements 116 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 114 .
  • Each of the one or more electrodes 114 is coupled to a corresponding conductive element 116 .
  • the conductive elements 116 are electrically isolated from each other and extend through the elongate body 102 from each respective electrode 114 through the first end 104 of the elongate body 102 .
  • the conductive elements 116 terminate at a connector port, where each of the conductive elements 116 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 116 are permanently coupled to the stimulation system (e.g., not releasably coupled).
  • the stimulation system can be used to provide stimulation electrical energy that is conducted through the conductive elements 116 and delivered across combinations of the one or more electrodes 114 .
  • the one or more electrodes 114 are electrically isolated from one another, where the elongate body 102 is formed of an electrically insulating material as discussed herein. As illustrated, the one or more electrodes 114 can be located only on the one surface of the three or more surfaces 112 of the elongate body 102 .
  • the one or more electrodes 114 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location.
  • the one or more electrodes 114 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 114 .
  • the electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other.
  • the electrodes in the array of electrodes can have a column and row configuration (as illustrated in FIG. 1 ).
  • the electrodes in the array of electrodes can have a concentric radial pattern, where the electrodes are positioned so as to form concentric rings of the electrodes. Other patterns are possible, where such patterns can either be repeating patterns or random patterns.
  • the one or more electrodes 114 have an exposed face 118 .
  • the exposed face 118 of the electrode 114 provides the opportunity for the electrode 114 , when implanted in the patient, to be placed into proximity and/or in contact with the vascular tissue of the patient, as opposed to facing into the volume of blood in the artery.
  • the electrodes 114 can be placed into direct proximity to and/or in contact with the tissue of any combination of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery.
  • the exposed face 118 of the electrode can be positioned inside the patient's vasculature to face and/or contact the tissue of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery.
  • the one or more electrodes 114 When the one or more electrodes 114 are in contact with luminal surface of the patient's vasculature, the one or more electrodes 114 will be pointing away from the majority of the blood volume of that region of the pulmonary artery. This allows the electrical pulses from the one or more electrodes 114 to be directed into the tissue adjacent the implant location, instead of being directed into the blood volume.
  • the exposed face 118 of the one or more electrodes 114 can have a variety of shapes.
  • the exposed face 118 can have a flat planar shape.
  • the exposed face 118 of the electrodes 114 can be co-planar with the one surface of the three or more surfaces 112 of the elongate body 102 .
  • the exposed face 118 of the electrodes 114 can have a semi-hemispherical shape.
  • Other shapes for the exposed face 118 of the electrodes 114 can include semi-cylindrical, wave-shaped, and zig-zag-shaped.
  • the exposed face 118 of the electrodes 114 can also include one or more anchor structures. Examples of such anchor structures include hooks that can optionally include a barb. Similarly, the electrodes can be shaped to also act as anchor structures.
  • the one surface of the three or more surfaces 112 of the elongate body 102 that include the exposed face 118 of the one or more electrodes 114 can further include anchor structures 120 that extend above the one surface of the three or more surfaces 112 .
  • the anchor structures 120 can include portions that can contact the vascular tissue in such a way that the movement of the one or more electrodes 114 at the location where they contact the vascular tissue is minimized.
  • the anchor structures 120 can have a variety of shapes that may help to achieve this goal.
  • the anchor structures 120 can have a conical shape, where the vertex of the conical shape can contact the vascular tissue.
  • the anchor structures 120 can have a hook configuration (with or without a barb).
  • the elongate body 102 of catheter 100 can also include a portion 122 with a circular cross-section shape taken perpendicularly to the longitudinal center axis 108 .
  • the elongate body 102 of catheter 100 also includes a surface 124 defining a guide-wire lumen 126 that extends through the elongate body 102 .
  • the guide-wire lumen 126 has a diameter that is sufficiently large to allow the guide wire to freely pass through the guide-wire lumen 126 .
  • the guide-wire lumen 126 can be positioned concentrically relative the longitudinal center axis 108 of the elongate body 102 .
  • the guide-wire lumen 126 is positioned eccentrically relative the longitudinal center axis 108 of the elongate body 102 .
  • the guide-wire lumen 126 will have a wall thickness 128 taken perpendicularly to the longitudinal center axis that is greater than a wall thickness 130 of a remainder of the catheter taken perpendicularly to the longitudinal center axis.
  • the differences in wall thickness 128 and 130 help to provide the elongate body 102 with a preferential direction in which to bend.
  • the wall thickness 128 of the elongate body 102 being greater than the wall thickness 130 will cause the side of the elongate body 102 with the greater wall thickness to preferentially have the larger radius of curvature when the elongate body 102 bends.
  • the exposed face 118 of the electrodes 114 on the side of the elongate body 102 having the great wall thickness (e.g., wall thickness 128 )
  • the one or more electrodes 114 can be more easily and predictably brought into contact with the luminal surface of the vasculature in and around the main pulmonary artery and at least one of the pulmonary arteries.
  • the catheter 100 shown in FIG. 1 can be positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision and guided to the right ventricle using known techniques.
  • the pulmonary artery guide catheter can be inserted into the vasculature via a peripheral vein of the arm (e.g., as with a peripherally inserted central catheter).
  • Other approaches can include, but are not limited to, an Internal Jugular approach, as is known. Changes in a patient's electrocardiography and/or pressure signals from the vasculature can be used to guide and locate the pulmonary artery guide catheter within the patient's heart.
  • a guide wire can be introduced into the patient via the pulmonary artery guide catheter, where the guide wire is advanced into the main pulmonary artery and/or one of the pulmonary arteries.
  • the catheter 100 can be advanced over the guide wire so as to position the catheter 100 in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • imaging modalities can be used in positioning the guide wire of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient.
  • imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • stimulation electrical energy can be delivered across combinations of one or more of the electrodes 114 . It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • FIG. 2 provides an additional embodiment of the catheter 200 as provided herein.
  • the catheter 200 includes the features and components as discussed above, a discussion of which is not repeated but the element numbers are included in FIG. 2 with the understanding that the discussion of these elements is implicit.
  • the elongate body 202 of the catheter 200 includes a serpentine portion 232 proximal to the one or more electrodes 214 .
  • the serpentine portion 232 of the elongate body 202 can act as a “spring” to absorb and isolate the movement of the one or more electrodes 214 from the remainder of the elongate body 202 of the catheter 200 .
  • the serpentine portion 232 can have a coil like configuration.
  • the catheter 300 can include the features and components as discussed above for catheters 100 and/or 200 , a discussion of which is not repeated but the element numbers are included in FIG. 3 with the understanding that the discussion of these elements is implicit.
  • the catheter 300 of the present embodiment includes an inflatable balloon 334 .
  • the elongate body 302 includes a peripheral surface 336 , where the inflatable balloon 334 is located on the peripheral surface 336 of the elongate body 302 .
  • the inflatable balloon 334 includes a balloon wall 338 with an interior surface 340 that along with a portion 342 of the peripheral surface 336 of the elongate body 302 defines a fluid tight volume 344 .
  • the elongate body 302 further includes a surface 345 that defines an inflation lumen 346 that extends through the elongate body 302 .
  • the inflation lumen 346 includes a first opening 348 into the fluid tight volume 344 of the inflatable balloon 334 and a second opening 350 proximal to the first opening 348 to allow for a fluid to move in the fluid tight volume 344 to inflate and deflate the balloon 334 .
  • a syringe, or other known devices, containing the fluid e.g., saline or a gas (e.g., oxygen)
  • the fluid e.g., saline or a gas (e.g., oxygen)
  • the catheter 300 shown in FIG. 3 can positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision, and guided to the right ventricle using known techniques.
  • the balloon 334 can be inflated, as described, to allow the catheter 300 to be carried by the flow of blood from the right ventricle to the main pulmonary artery and/or one of the pulmonary arteries.
  • various imaging modalities can be used in positioning the catheter of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • the catheter 300 can be advance along the main pulmonary artery until the second end 306 of the catheter 300 contacts the top of the main pulmonary artery (e.g., a location distal to the pulmonary valve and adjacent to both the pulmonary arteries). Once the second end 306 of the catheter 300 reaches the top of the main pulmonary artery the pulmonary artery guide catheter can be moved relative the catheter 300 so as to deploy the catheter 300 from the pulmonary artery guide catheter.
  • Markings can be present on the peripheral surface of the catheter body 302 , where the markings start and extend from the first end 302 towards the second end 306 of the catheter body 302 .
  • the distance between the markings can be of units (e.g., millimeters, inches, etc.), which can allow the length between the second end 306 of the catheter 300 and the top of the main pulmonary artery to be determined.
  • the ability to measure this distance from the top of the main pulmonary artery may be helpful in placing the one or more electrodes 314 in a desired location within the main pulmonary artery.
  • the elongate body 302 can also be used to identify, or map, an optimal position for the one or more electrodes 314 within the vasculature.
  • the second end 306 of the elongate body 302 can be positioned at the desired distance from the top of the main pulmonary artery using the markings on the peripheral surface of the catheter body 302 .
  • stimulation electrical energy can be delivered across combinations of the one or more electrodes 314 . It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • the catheter 400 can include the features and components as discussed above for catheters 100 , 200 and/or 300 , a discussion of which is not repeated but the element numbers are included in FIG. 4 with the understanding that the discussion of these elements is implicit.
  • the catheter 400 of the present embodiment includes a surface 452 defining a deflection lumen 454 .
  • the deflection lumen 454 includes a first opening 456 and a second opening 458 in the elongate body 402 .
  • the second opening 458 can be opposite the one or more electrodes 414 on one surface of the three or more surfaces 412 of the elongate body 402 .
  • the catheter 400 further includes an elongate deflection member 460 .
  • the elongate deflection member 460 includes an elongate body 461 having a first end 463 and a second end 465 .
  • the elongate deflection member 460 extends through the first opening 456 to the second opening 458 of the deflection lumen 454 .
  • the deflection lumen 454 has a size (e.g., a diameter) sufficient to allow the deflection member 460 to pass through the deflection lumen 454 with the first end 463 of the deflection member 460 proximal to the first end 404 of the elongate body 402 and the second end 465 of the deflection member 460 extendable from the second opening 458 of the deflection lumen 454 .
  • Pressure applied from the first end 463 of the deflection member 460 can cause the deflection member 460 to move within the deflection lumen 454 .
  • the pressure when pressure is applied to the deflection member 460 to move the first end 463 of the deflection member 460 towards the first opening 456 of the deflection lumen 454 , the pressure causes the second end 465 of the deflection member 460 to extend from the second opening 458 .
  • the elongate deflection member 460 can be advanced through the deflection lumen 454 so that elongate deflection member 460 extends laterally away from the one or more electrodes 414 on the one surface of the three or more surfaces 412 of the elongate body 402 .
  • the elongate deflection member 460 can be of a length and shape that allows the elongate deflection member 460 to be extended a distance sufficient to bring the one or more electrodes 414 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures.
  • the elongate deflection member 460 can be configured to include one or more of the electrode 414 , as discussed herein.
  • the elongate body 461 of the deflection member 460 is formed of a flexible polymeric material.
  • flexible polymeric material include, but are not limited to, medical grade polyurethanes, such as polyester-based polyurethanes, polyether-based polyurethanes, and polycarbonate-based polyurethanes; polyamides, polyamide block copolymers, polyolefins such as polyethylene (e.g., high density polyethylene); and polyimides, among others.
  • the elongate body 461 of the elongate deflection member 460 can also include one or more support wires.
  • the support wires can be encased in the flexible polymeric material of the elongate body 461 , where the support wires can help to provide both column strength and a predefined shape to the elongate deflection member 460 .
  • the support wires can have a coil shape that extends longitudinally along the length of the elongate body 461 .
  • the coil shape allows for the longitudinal force applied near or at the first end 463 of the deflection member 460 to be transferred through the elongate body 461 so as to laterally extend the second end 465 of the deflection member 460 from the second opening 458 of the deflection lumen 454 .
  • the support wires can also provide the deflection member 460 with a predetermined shape upon laterally extending from the second opening 458 of the deflection lumen 454 .
  • the predetermined shape can be determined to engage the luminal wall of the pulmonary artery in order to bring the electrodes 414 into contact with the vascular tissue.
  • the predetermined shape and the support wires can also help to impart stiffness to the deflection member 460 that is sufficient to maintain the electrodes 414 on the luminal wall of the pulmonary artery under the conditions within the vasculature of the patient.
  • the support wires can be formed of a variety of metals or metal alloys.
  • metals or metal alloys include surgical grade stainless steel, such as austenitic 316 stainless among others, and the nickel and titanium alloy known as Nitinol.
  • Other metals and/or metal alloys, as are known, can be used.
  • the catheter 400 shown in FIG. 4 can positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision, and guided to the right ventricle using known techniques.
  • the balloon 434 can be inflated, as described, to allow the catheter 400 to be carried by the flow of blood from the right ventricle to the main pulmonary artery and/or one of the pulmonary arteries.
  • various imaging modalities can be used in positioning the catheter of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • the catheter 400 can be advance along the main pulmonary artery until the second end 406 of the catheter 400 contacts the top of the main pulmonary artery (e.g., a location distal to the pulmonary valve and adjacent to both the pulmonary arteries). Once the second end 406 of the catheter 400 reaches the top of the main pulmonary artery the pulmonary artery guide catheter can be moved relative the catheter 400 so as to deploy the catheter 400 from the pulmonary artery guide catheter.
  • Markings can be present on the peripheral surface of the catheter body 402 that can assist in positioning the catheter 400 within the main pulmonary artery.
  • the ability to measure this distance from the top of the main pulmonary artery may be helpful in placing the one or more electrodes 414 in a desired location within the main pulmonary artery.
  • the elongate body 402 can also be used to identify, or map, an optimal position for the one or more electrodes 414 within the vasculature.
  • the second end 406 of the elongate body 402 can be positioned at the desired distance from the top of the main pulmonary artery using the markings on the peripheral surface of the catheter body 402 .
  • the elongate deflection member 460 can be extended laterally from the elongate body 402 to a distance sufficient to cause the one surface of the three or more surfaces 412 of the elongate body 402 having the one or more electrodes to contact a surface of the main pulmonary artery, such as the anterior surface of the main pulmonary artery, and thereby bring the one or more electrodes 414 into contact with the main pulmonary artery or one of the pulmonary arteries (the left pulmonary artery or the right pulmonary artery).
  • the elongate deflection member 460 biases and helps to place the one or more electrodes 414 along the vessel surface (e.g., along the posterior surface of the main pulmonary artery or one of the pulmonary arteries (the left pulmonary artery or the right pulmonary artery)).
  • the elongate deflection member 460 can be used to bring the one or more electrodes 414 into contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries with a variety of pressures. So, for example, the elongate deflection member 460 can bring the one or more electrodes 414 into contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries with a first pressure.
  • stimulation electrical energy can be delivered across combinations of the one or more electrodes 414 in the electrode array. It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests.
  • any combination of electrodes including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • the distance the elongate deflection member 460 extends laterally from the elongate body 402 can be changed (e.g., made shorter) to allow the elongate body 402 to be rotated in either a clockwise or counter-clockwise direction, thereby repositioning the one or more electrodes 414 in contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries.
  • the stimulation system can again be used to deliver stimulation electrical energy across combinations of one or more of the electrodes 414 in the electrode array.
  • the patient's cardiac response to this subsequent test can then be monitored and recorded for comparison to previous and subsequent test.
  • the elongate deflection member 460 can be used to increase the lateral pressure applied to the one or more electrodes, thereby helping to better anchor the catheter 400 in the patient.
  • the catheter 562 includes an elongate body 502 having a peripheral surface 536 and a longitudinal center axis 508 extending between a first end 504 and a second end 506 .
  • the catheter 562 can include the features and components as discussed above for catheters 100 , 200 , 300 and/or 400 , a discussion of which is not repeated but the element numbers are included in FIG. 5 with the understanding that the discussion of these elements is implicit.
  • the catheter 562 of the present embodiment includes an inflatable balloon 534 .
  • the elongate body 502 includes a peripheral surface 536 , where the inflatable balloon 534 is located on the peripheral surface 536 of the elongate body 502 .
  • the inflatable balloon 534 includes a balloon wall 538 with an interior surface 540 that along with a portion 542 of the peripheral surface 536 of the elongate body 502 defines a fluid tight volume 544 .
  • the elongate body 502 further includes a surface 545 that defines an inflation lumen 546 that extends through the elongate body 502 .
  • the inflation lumen 546 includes a first opening 548 into the fluid tight volume 544 of the inflatable balloon 534 and a second opening 550 proximal to the first opening 548 to allow for a fluid to move in the fluid tight volume 544 to inflate and deflate the balloon 534 .
  • a syringe, or other known devices, containing the fluid e.g., saline or a gas (e.g., oxygen)
  • the fluid e.g., saline or a gas (e.g., oxygen)
  • the elongate body 502 further includes an offset region 564 defined by a series of predefined curves along the longitudinal center axis 508 .
  • predefined curves are curves formed in the elongate body 502 during the production of the catheter 562 , where when deformed such curves provide a spring like force to return to their pre-deformation shape (i.e., their original shape).
  • the series of predefined curves includes a first portion 566 that has a first curve 568 in the longitudinal center axis 508 followed by a second curve 570 in the longitudinal center axis 508 of the elongate body 502 .
  • each of the first curve 568 and second curve 570 along with the distance between such curves helps to define the height of the offset region 564 .
  • the height of the offset region 564 can be determined by the inner diameter of one or more locations along the main pulmonary artery and/or one of the pulmonary arteries.
  • the first portion 566 of the elongate body 502 is followed by a second portion 572 of the elongate body 502 .
  • the longitudinal center axis 508 along the second portion 572 can have a zero curvature (i.e., a straight line), as illustrated in FIG. 5 .
  • the second portion 572 of the elongate body 502 is followed by a third portion 574 of the elongate body 502 .
  • the longitudinal center axis 508 transitions from the second portion 572 along a third curve 576 , which then transitions into a fourth curve 578 .
  • the longitudinal center axis 508 is approximately co-linear with the longitudinal center axis 508 leading up to the first curve 568 .
  • the curves of the first portion 566 and the second portion 574 can also all be in approximately the same plane. It is, however, possible that the curves of the first portion 566 and the second portion 574 are not in the same plane.
  • the longitudinal center axis 508 can include a helical curve through these portions of the elongate body 502 . Other shapes are possible.
  • the elongate body 502 can further include one or more electrodes 514 , as discussed herein, along the second portion 572 of the offset region 564 of the elongate body 502 .
  • the one or more electrodes 514 can be on the surface of the elongate body 502 in the second portion 572 of the offset region 564 .
  • Conductive elements 516 extend through the elongate body 502 , where the conductive elements 516 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 514 .
  • Each of the one or more electrodes 514 is coupled to a corresponding conductive element 516 .
  • the conductive elements 516 are electrically isolated from each other and extend through the elongate body 502 from each respective electrode 514 through the first end 504 of the elongate body 502 .
  • the conductive elements 516 terminate at a connector port, where each of the conductive elements 516 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 516 are permanently coupled to the stimulation system (e.g., not releasably coupled).
  • the stimulation system can be used to provide stimulation electrical energy that is conducted through the conductive elements 516 and delivered across combinations of the one or more electrodes 514 .
  • the one or more electrodes 514 are electrically isolated from one another, where the elongate body 502 is formed of an electrically insulating material as discussed herein.
  • the one or more electrodes 514 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location.
  • the one or more electrodes 514 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 514 .
  • the electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other. So, for example, the electrodes in the array of electrodes can have a column and row configuration.
  • the electrodes in the array of electrodes can have a concentric radial pattern, where the electrodes are positioned so as to form concentric rings of the electrodes.
  • Other patterns are possible, where such patterns can either be repeating patterns or random patterns.
  • the catheter 562 further includes conductive elements 516 extending through the elongate body, where the conductive elements 516 conduct electrical current to combinations of the one or more electrodes 514 .
  • the length and degree of each of the curves, along with the distance between such curves, helping to define the first portion 566 and the third portion 574 of the longitudinal center axis 508 helps to define the relative height of the offset region 564 .
  • the height of the offset region 564 can be determined by the inner diameter of one or more locations along the main pulmonary artery and/or one of the pulmonary arteries. In this way the first portion 566 and the third portion 574 can bring the second portion 572 and the one or more electrodes 514 on the surface of the elongate body 502 into contact with the vascular wall of the patient in the main pulmonary artery and/or one of the pulmonary arteries.
  • transitions of the first portion 566 and the third portion 574 of the elongate body 502 in the offset region 564 can act to bias the second portion 572 and the one or more electrodes 514 against the vascular wall of the patient in the main pulmonary artery and/or one of the pulmonary arteries.
  • the elongate body 502 further includes a surface 524 defining a guide-wire lumen 526 that extends through the elongate body 502 .
  • the guide-wire lumen 526 can be concentric relative the longitudinal center axis 508 of the elongate body 502 (as illustrated in FIG. 5 ).
  • the guide-wire lumen 526 can be eccentric relative the longitudinal center axis 508 of the elongate body 502 .
  • the guide-wire lumen 526 can have a wall thickness 528 that is greater than a wall thickness 530 of a remainder of the catheter 562 taken perpendicularly to the longitudinal center axis 508 .
  • a wall thickness 528 that is greater than a wall thickness 530 of a remainder of the catheter 562 taken perpendicularly to the longitudinal center axis 508 .
  • a portion of the elongate body 502 includes a serpentine portion, as discussed and illustrated herein, proximal to the one or more electrodes 514 .
  • a guide-wire used with the catheter 562 can serve to temporarily “straighten” the offset region 564 when the guide-wire is present in the guide-wire lumen 526 that passes along the offset region 564 .
  • the guide-wire can be used to impart the shape of the offset region 564 to the catheter 562 .
  • the elongate body 502 of the catheter 562 can have a straight shape (e.g., no predefined lateral shape).
  • the guide wire is “shaped” (e.g., bent) to the desired configuration of the offset region at point that corresponds to the desired longitudinal location for the offset region on the elongate body 502 .
  • the offset region 564 of the catheter 562 can be provided by inserting the guide wire with the predefined lateral shape.
  • the catheter 562 of the present embodiment further includes a surface 552 defining a deflection lumen 554 , as discussed herein.
  • the catheter 562 further includes an elongate deflection member 560 , also as discussed herein.
  • the elongate deflection member 560 can be advanced through the deflection lumen 554 so that elongate deflection member 560 extends laterally away from the one or more electrodes 514 on the second portion 572 of the elongate body 502 .
  • the elongate deflection member 560 can be of a length and shape that allows the elongate deflection member 560 to be extended a distance sufficient to bring the one or more electrodes 514 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures.
  • the vascular luminal surface e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries
  • the elongate body 561 of the elongate deflection member 560 can also include one or more support wires 581 .
  • the support wires 581 can be encased in the flexible polymeric material of the elongate body 561 , where the support wires 581 can help to provide both column strength and a predefined shape to the elongate deflection member 560 .
  • the support wires 581 can have a coil shape that extends longitudinally along the length of the elongate body 561 .
  • the coil shape allows for the longitudinal force applied near or at the first end 563 of the deflection member 560 to be transferred through the elongate body 561 so as to laterally extend the second end 565 of the deflection member 560 from the second opening 558 of the deflection lumen 554 .
  • the support wires 581 can also provide the deflection member 560 with a predetermined shape upon laterally extending from the second opening 558 of the deflection lumen 554 .
  • the predetermined shape can be determined to engage the luminal wall of the pulmonary artery in order to bring the electrodes 514 on the second portion 572 of the offset region 564 into contact with the vascular tissue.
  • the predetermined shape and the support wires 581 can also help to impart stiffness to the deflection member 560 that is sufficient to maintain the electrodes 514 on the luminal wall of the pulmonary artery under the conditions within the vasculature of the patient.
  • the support wires 581 can be formed of a variety of metals or metal alloys.
  • metals or metal alloys include surgical grade stainless steel, such as austenitic 316 stainless among others, and the nickel and titanium alloy known as Nitinol.
  • Other metals and/or metal alloys, as are known, can be used.
  • the catheter 662 can include the features and components as discussed above for catheters 100 , 200 , 300 , 400 and/or 500 , a discussion of which is not repeated but the element numbers are included in FIG. 6 with the understanding that the discussion of these elements is implicit.
  • the catheter 662 seen in FIG. 6 is similar to the catheter 562 of FIG. 5 , where the elongate body 602 of catheter 662 further includes three or more surfaces 612 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 608 , as discussed for the catheters 100 , 200 , 300 and 400 herein.
  • the one or more electrodes 614 are on one surface of the three or more surfaces 612 of the elongate body 602 .
  • the three or more surfaces 612 of the elongate body 602 help to form the second portion 672 of the elongate body 602 .
  • the elongate body 602 can includes a serpentine portion proximal to the one or more electrodes 614 .
  • the catheter 782 can include the features and components as discussed above for catheters 100 , 200 , 300 , 400 , 500 and/or 600 , a discussion of which is not repeated but the element numbers are included in FIG. 7 with the understanding that the discussion of these elements is implicit.
  • the catheter 782 includes an elongate body 702 having a peripheral surface 736 and a longitudinal center axis 708 extending between a first end 704 and a second end 706 .
  • the elongate body 702 includes a surface 752 defining a deflection lumen 754 , where the deflection lumen 754 includes a first opening 756 and a second opening 758 in the elongate body 702 .
  • the catheter 782 further includes an inflatable balloon 734 on the peripheral surface 736 of the elongate body 702 , the inflatable balloon 734 having a balloon wall 738 with an interior surface 740 that along with a portion 742 of the peripheral surface 736 of the elongate body 702 defines a fluid tight volume 744 , as discussed herein.
  • An inflation lumen 746 extends through the elongate body 702 , where the inflation lumen 746 has a first opening 748 into the fluid tight volume 744 of the inflatable balloon 734 and a second opening 750 proximal to the first opening 748 to allow for a fluid to move in the fluid tight volume 744 to inflate and deflate the balloon 734 .
  • One or more electrodes 714 are on the elongate body 702 , where the second opening 758 of the deflection lumen 754 is opposite the one or more electrodes 714 on the elongate body 702 .
  • the catheter 782 further includes an elongate deflection member 760 , as discussed herein, where the elongate deflection member 760 extends through the second opening 758 of the deflection lumen 754 in a direction opposite the one or more electrodes 714 on one surface of the elongate body 702 .
  • the catheter 782 also includes conductive elements 716 , as discussed herein, that extend through the elongate body 702 , where the conductive elements 716 conduct electrical current to combinations of the one or more electrodes 714 .
  • the catheter 782 further includes a surface 724 defining a guide-wire lumen 726 that extends through the elongate body 702 .
  • the guide-wire lumen 726 is concentric relative the longitudinal center axis 708 .
  • the guide-wire lumen 726 could also be eccentric relative longitudinal center axis 708 of the elongate body 708 .
  • the guide-wire lumen 726 can have a wall thickness taken perpendicularly to the longitudinal center axis 708 that is greater than a wall thickness of a remainder of the catheter 782 taken perpendicularly to the longitudinal center axis 708 .
  • the catheter 782 can also include a serpentine portion of the elongate body 702 proximal to the one or more electrodes 714 , as discussed herein.
  • the catheter 882 can include the features and components as discussed above for catheters 100 , 200 , 300 , 400 , 500 , 600 and/or 700 , a discussion of which is not repeated but the element numbers are included in FIG. 8 with the understanding that the discussion of these elements is implicit.
  • the catheter 882 includes an elongate body 802 having a peripheral surface 836 and a longitudinal center axis 808 extending between a first end 804 and a second end 806 .
  • the elongate body 802 includes a surface 852 defining a deflection lumen 854 , where the deflection lumen 854 includes a first opening 856 and a second opening 858 in the elongate body 802 .
  • the catheter 882 further includes an inflatable balloon 834 on the peripheral surface 836 of the elongate body 802 , the inflatable balloon 834 having a balloon wall 838 with an interior surface 840 that along with a portion 842 of the peripheral surface 836 of the elongate body 802 defines a fluid tight volume 844 , as discussed herein.
  • An inflation lumen 846 extends through the elongate body 802 , where the inflation lumen 846 has a first opening 848 into the fluid tight volume 844 of the inflatable balloon 834 and a second opening 850 proximal to the first opening 848 to allow for a fluid to move in the fluid tight volume 844 to inflate and deflate the balloon 834 .
  • One or more electrodes 814 are on the elongate body 802 , where the second opening 858 of the deflection lumen 854 is opposite the one or more electrodes 814 on the elongate body 802 .
  • the elongate body 802 has three or more surfaces 812 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 808 .
  • the one or more electrodes 814 are on one surface of the three or more surfaces 812 of the elongate body 802 , as discussed herein.
  • the catheter 882 further includes an elongate deflection member 860 , as discussed herein, where the elongate deflection member 860 extends through the second opening 858 of the deflection lumen 854 in a direction opposite the one or more electrodes 814 on one surface of the elongate body 802 .
  • the catheter 882 also includes conductive elements 816 , as discussed herein, that extend through the elongate body 802 , where the conductive elements 816 conduct electrical current to combinations of the one or more electrodes 814 .
  • the catheter 882 further includes a surface 824 defining a guide-wire lumen 826 that extends through the elongate body 802 .
  • the guide-wire lumen 826 is concentric relative the longitudinal center axis 808 .
  • the guide-wire lumen 826 could also be eccentric relative longitudinal center axis 808 of the elongate body 808 .
  • Such embodiments are discussed herein, where the guide-wire lumen 826 can have a wall thickness taken perpendicularly to the longitudinal center axis 808 that is greater than a wall thickness of a remainder of the catheter 882 taken perpendicularly to the longitudinal center axis 808 .
  • the catheter 882 can also include a serpentine portion of the elongate body 802 proximal to the one or more electrodes 814 , as discussed herein.
  • the catheter 984 can include the features and components as discussed above for catheters 100 , 200 , 300 , 400 , 500 , 600 , 700 and/or 800 , a discussion of which is not repeated but the element numbers are included in FIG. 9 with the understanding that the discussion of these elements is implicit.
  • the catheter 984 includes an elongate body 902 having a peripheral surface 936 and a longitudinal center axis 908 extending between a first end 904 and a second end 906 .
  • the catheter 984 further includes an inflatable balloon 934 on the peripheral surface 936 of the elongate body 902 , the inflatable balloon 934 having a balloon wall 938 with an interior surface 940 that along with a portion 942 of the peripheral surface 936 of the elongate body 902 defines a fluid tight volume 944 , as discussed herein.
  • An inflation lumen 946 extends through the elongate body 902 , where the inflation lumen 946 has a first opening 948 into the fluid tight volume 944 of the inflatable balloon 934 and a second opening 950 proximal to the first opening 948 to allow for a fluid to move in the fluid tight volume 944 to inflate and deflate the balloon 934 .
  • the catheter 982 includes a surface 924 defining a guide-wire lumen 926 that extends through the elongate body 902 .
  • the guide-wire lumen 926 is concentric relative the longitudinal center axis 908 .
  • the guide-wire Lumen 926 could also be eccentric relative longitudinal center axis 908 of the elongate body 908 .
  • the guide-wire lumen 926 can have a wall thickness taken perpendicularly to the longitudinal center axis 908 that is greater than a wall thickness of a remainder of the catheter 982 taken perpendicularly to the longitudinal center axis 908 .
  • the catheter 982 can also include a serpentine portion of the elongate body 902 proximal to the one or more electrodes 914 , as discussed herein.
  • the elongate body 902 of the catheter 984 further includes a surface 986 defining an electrode lumen 988 .
  • the electrode lumen 988 includes a first opening 990 and a second opening 992 in the elongate body 902 .
  • the catheter 984 also includes an elongate electrode member 994 , where the elongate electrode member 994 retractably extends through the first opening 990 of the electrode lumen 988 of the elongate body 902 .
  • the electrode lumen 988 has a size (e.g., a diameter) sufficient to allow the elongate electrode member 994 to pass through the electrode lumen 988 to that the elongate electrode member 994 can retractably extend through the first opening 990 of the electrode lumen 988 of the elongate body 902 .
  • the elongate electrode member 994 can retractably extend through the first opening 990 of the electrode lumen 988 of the elongate body 902 from pressure (e.g., compression or tension) applied by the user through the elongate electrode member 994 proximal to the second opening 992 in the elongate body 908 .
  • the elongate electrode member 994 is formed of a flexible polymeric material. Examples of such flexible polymeric material include, but are not limited to, those provided herein.
  • the elongate electrode member 994 includes one or more electrodes 996 and conductive elements 998 extending through the electrode lumen 988 . As illustrated, the one or more electrodes 996 are on the surface 901 of the elongate electrode member 994 . Conductive elements 998 extend through the elongate electrode member 994 , where the conductive elements 998 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 996 . Each of the one or more electrodes 996 is coupled to a corresponding conductive element 998 .
  • the conductive elements 998 are electrically isolated from each other and extend through the elongate electrode member 994 from each respective electrode 996 through the second end 992 of the electrode lumen 988 .
  • the conductive elements 998 terminate at a connector port, where each of the conductive elements 998 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 998 are permanently coupled to the stimulation system (e.g., not releasably coupled).
  • the stimulation system can be used to conduct electrical current to combinations of the one or more electrodes 994 via the conductive elements 998 .
  • the one or more electrodes 996 are electrically isolated from one another, where the elongate electrode member 994 is formed of an electrically insulating material as discussed herein.
  • the one or more electrodes 996 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location.
  • the one or more electrodes 996 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 996 .
  • the electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other. Other patterns are possible, where such patterns can either be repeating patterns or random patterns.
  • the one or more electrodes 996 have an exposed face 903 .
  • the exposed face 903 of the electrode 996 provides the opportunity for the electrode 996 , when implanted in the patient, to be placed into proximity and/or in contact with the vascular tissue of the patient, as opposed to facing into the volume of blood in the artery.
  • the one or more electrodes 996 can be located on only one side of the elongate electrode member 994 (as illustrated in FIG. 9 ). This allows the one or more electrodes 996 to be brought into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries).
  • the electrodes 996 can be placed into direct proximity to and/or in contact with, the tissue of any combination of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery.
  • the exposed face 903 of the one or more electrodes 996 can have a variety of shapes, as discussed herein (e.g., a partial ring configuration, where each of the one or more electrodes 996 is positioned to face away from the elongate body 902 ).
  • the exposed face 903 of the electrodes 996 can also include one or more anchor structures. Examples of such anchor structures include hooks that can optionally include a barb.
  • the elongate electrode member 994 can be advanced through the electrode lumen 988 so that the elongate electrode member 994 extends laterally away from the elongate body 908 .
  • the elongate electrode member 994 can be of a length and shape that allows the elongate electrode member 994 to be extended a distance sufficient from the elongate body 908 to bring the one or more electrodes 996 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries).
  • the vascular luminal surface e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries.
  • the elongate electrode member 994 forms a loop 905 that extends away from the peripheral surface 936 of the elongate body 902 .
  • the loop 905 can have a variety of configurations relative the longitudinal axis 908 of the elongate body 902 .
  • the elongate electrode member 992 forming the loop 905 is in a plane 907 that is co-linear with the longitudinal center axis 908 of the elongate body 902 .
  • the catheter 984 further includes an elongate deflection member 960 , as previously discussed.
  • pressure is applied to the deflection member 960 to move the first end 963 of the deflection member 960 towards the first opening 956 of the deflection lumen 954 .
  • the pressure in addition to moving the first end 963 of the deflection member 960 towards the first opening 956 also causes the second end 965 of the deflection member 960 to extend from the second opening 958 .
  • the elongate deflection member 960 can be advanced through the deflection lumen 954 so that elongate deflection member 960 extends laterally away from the one or more electrodes 996 on the elongate electrode member 994 .
  • the elongate deflection member 960 can be of a length and shape that allows the elongate deflection member 960 to be extended a distance sufficient to help bring the one or more electrodes 996 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures.
  • the elongate deflection member 960 can be configured to include one or more of the electrode, as discussed herein.
  • the catheter 984 shown in FIG. 9 can be positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision and guided to the right ventricle using known techniques.
  • the pulmonary artery guide catheter can be inserted into the vasculature via a peripheral vein of the arm (e.g., as with a peripherally inserted central catheter). Changes in a patient's electrocardiography and/or pressure signals from the vasculature can be used to guide and locate the pulmonary artery guide catheter within the patient's heart.
  • a guide wire can be introduced into the patient via the pulmonary artery guide catheter, where the guide wire is advanced into the main pulmonary artery and/or one of the pulmonary arteries.
  • the catheter 984 can be advanced over the guide wire so as to position the catheter 984 in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein.
  • imaging modalities can be used in positioning the guide wire of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient.
  • imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • stimulation electrical energy can be delivered across combinations of one or more of the electrodes 996 . It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • the catheter 1084 can include the features and components as discussed above for catheters 100 , 200 , 300 , 400 , 500 , 600 , 700 , 800 and/or 900 , a discussion of which is not repeated but the element numbers are included in FIG. 10 with the understanding that the discussion of these elements is implicit.
  • the catheter 1084 illustrates an embodiment in which the elongate electrode member 1094 forms the 1005 loop in a plane 1007 that is perpendicular to the longitudinal center axis of the elongate body.
  • elongate electrode member can be used with a catheter.
  • the electrode can have a variety of configurations and sizes.
  • the electrodes discussed herein can be ring-electrodes that fully encircle the body on which they are located.
  • the electrodes discussed herein can also be a partial ring, where the electrode only partially encircles the body on which they are located.
  • the electrodes can be partial ring electrodes that preferably only contact the luminal surface of the main pulmonary artery and/or pulmonary arteries, as discussed herein. This configuration may help to localize the stimulation electrical energy, as discussed herein, into the vascular and adjacent tissue structures (e.g., autonomic fibers) and away from the blood.
  • the electrodes and conductive elements provided herein can be formed of a conductive biocompatible metal or metal alloy.
  • conductive biocompatible metal or metal alloys include, but are not limited to, titanium, platinum or alloys thereof.
  • Other biocompatible metal or metal alloys are known.
  • the elongate body of the catheters provided herein can be formed of a flexible polymeric material.
  • flexible polymeric material include, but are not limited to, medical grade polyurethanes, such as polyester-based polyurethanes, polyether-based polyurethanes, and polycarbonate-based polyurethanes; polyamides, polyamide block copolymers, polyolefins such as polyethylene (e.g., high density polyethylene); and polyimides, among others.
  • Each of the catheters discussed herein can further include one or more reference electrodes positioned proximal to the one or more electrodes present on the elongate body.
  • These one or more reference electrodes each include insulated conductive leads that extend from the catheter so as to allow the one or more reference electrodes to be used as common or return electrodes for electrical current that is delivered through one or more of the one or more electrodes on the elongate body of the catheter.
  • the catheters of the present disclosure can be used to treat a patient with various cardiac conditions. Such cardiac conditions include, but are not limited to, acute heart failure, among others.
  • cardiac conditions include, but are not limited to, acute heart failure, among others.
  • the one or more electrodes present on the catheter can be positioned within the main pulmonary artery and/or one or both of the pulmonary arteries. Preferably, the one or more electrodes are positioned in contact the luminal surface of the main pulmonary artery (e.g., in physical contact with the surface of the posterior portion of the main pulmonary artery).
  • the one or more electrodes on the catheter provided herein can be used to provide pulse of electrical energy between the electrodes and/or the reference electrodes.
  • the electrodes of the present disclosure can be used in any one of a unipolar, bi-polar and/or a multi-polar configuration.
  • the catheter of the present disclosure can provide the stimulation electrical energy to stimulate the nerve fibers (e.g., autonomic nerve fibers) surrounding the main pulmonary artery and/or one or both of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient (e.g., electrical cardiac neuromodulation).
  • nerve fibers e.g., autonomic nerve fibers
  • one or more sensing electrodes can be located on or within the patent.
  • the sensing electrodes can be used to detect signals indicting changes in various cardiac parameters, where these changes can be the result of the pulse of stimulation electrical energy delivered to stimulate the nerve fibers (e.g., autonomic nerve fibers) surrounding the main pulmonary artery and/or one or both of the pulmonary arteries.
  • Such parameters include, but are not limited to, the patient's heart rate (e.g., pulse), among other parameters.
  • the sensing electrodes can also provide signals indicting changes in one or more electrical parameter of vasculature (electrical activity of the cardiac cycle).
  • Such signals can be collected and displayed, as are known, using known devices (e.g., electrocardiography (ECG) monitor) or a stimulation system, as discussed herein, which receives the detected signals and provides information about the patient.
  • ECG electrocardiography
  • catheter of the present disclosure can further include a pressure sensor positioned within or in-line with the inflation lumen for the inflatable balloon. Signals from the pressure sensor can be used to both detect and measure the blood pressure of the patient.
  • catheter of the present disclosure can include an integrated circuit for sensing and measuring blood pressure and/or a blood oxygen level. Such an integrated circuit can be implemented using 0.18 ⁇ m CMOS technology.
  • the oxygen sensor can be measured with optical or electrochemical techniques as are known.
  • the elongate body of the catheter can include the sensor (e.g., a blood oxygen sensor and/or a pressure sensor) and a conductive element, or elements, extending through each of the elongate body, where the conductive element conducts electrical signals from the blood oxygen sensor and/or the pressure sensor.
  • the sensor e.g., a blood oxygen sensor and/or a pressure sensor
  • a conductive element, or elements extending through each of the elongate body, where the conductive element conducts electrical signals from the blood oxygen sensor and/or the pressure sensor.
  • the detected signals can also be used by the stimulation system to provide stimulation electrical energy in response to the detected signals.
  • one or more of these signals can be used by the stimulation system to deliver the stimulation electrical energy to the one or more electrodes of the catheter.
  • detected signals from the patent's cardiac cycle e.g., ECG waves, wave segments, wave intervals or complexes of the ECG waves
  • the stimulation system can receive these detected signals and based on the features of the signal(s) generate and deliver the stimulation electrical energy to the one or more electrode of the catheter.
  • the stimulation electrical energy is of sufficient current and potential along with a sufficient duration to stimulate one or more of the nerve fibers surrounding the main pulmonary artery and/or one or both of the pulmonary arteries so as to provide neuromodulation to the patient.
  • FIG. 11 there is shown an illustration of a main pulmonary artery 11500 of a heart 11502 .
  • the main pulmonary artery 11500 begins at the base of the right ventricle 11504 , having a diameter of approximately 3 centimeter (1.2 in) and a length of about approximately 5 centimeters (2.0 in).
  • the main pulmonary artery 11500 branches into two pulmonary arteries (left and right) 11501 , which deliver deoxygenated blood to the corresponding lung.
  • the main pulmonary artery 11500 has a posterior surface 11506 that arches over the left atrium and is adjacent the pulmonary vein.
  • the one or more electrodes of the catheter of the present disclosure are positioned at least partially within the main pulmonary artery and/or a pulmonary artery with the electrode in contact with the posterior surface 11506 .
  • One preferred location for positioning the one or more electrodes of the catheter of the present disclosure is the right pulmonary artery as disclosed in U.S. Provisional Patent Application 62/______ entitled “METHODS FOR ELECTRICAL NEUROMODULATION OF THE HEART” filed on Sep. 8, 2014, which is incorporated herein by reference in its entirety.
  • Other locations along the lumen of the main pulmonary artery and/or pulmonary arteries are also possible.
  • the one or more electrodes of the catheter of the present disclosure are in contact with the posterior surface 11506 of the main pulmonary artery 11500 and/or pulmonary arteries 11501 .
  • the stimulation electrical energy delivered through the one or more electrodes may be better able to treat and/or provide therapy (including adjuvant therapy) to the patient experiencing a variety of cardiovascular medical conditions, such as acute heart failure.
  • the stimulation electrical energy can elicit responses from the autonomic nervous system that may help to modulate a patient's cardiac contractility.
  • the stimulation electrical energy is intended to affect heart contractility more than the heart rate, thereby helping to improving hemodynamic control while possibly minimizing unwanted systemic effects.
  • the catheter of the present disclosure can be positioned in the pulmonary artery of the patient, where the one or more electrodes are positioned in contact the luminal surface of the main pulmonary artery (e.g., in physical contact with the surface of the posterior portion of the main pulmonary artery).
  • the stimulation system is electrically coupled to the one or more electrodes via the conductive elements, where the stimulation system can be used to deliver the stimulation electrical energy to the autonomic cardiopulmonary fibers surrounding the main pulmonary artery.
  • the stimulation system is used to operate and supply the stimulation electrical energy to the one or more electrodes of the catheter.
  • the stimulation system controls the various parameters of the stimulation electrical energy delivered across the one or more electrodes. Such parameters include control of each electrodes polarity (e.g., used as a cathode or an anode), pulsing mode (e.g., unipolar, bi-polar and/or multi-polar), a pulse width, an amplitude, a frequency, a voltage, a current, a duration, a wavelength and/or a waveform associated with the stimulation electrical energy.
  • the stimulation system may operate and supply the stimulation electrical energy to different combinations and numbers of the one or more electrodes, including the reference electrodes discussed herein.
  • the stimulation system can be external to the patient's body for use by the professional to program the stimulation system and to monitor its performance.
  • the stimulation system could be internal to the patient's body.
  • the housing of the stimulation system can be used as a reference electrode for both sensing and unipolar pulsing mode.
  • the stimulation system can be used to help identify a preferred location for the position of the one or more electrodes along the luminal surface of the main pulmonary artery.
  • the one or more electrodes of the catheter are introduced into the patient and tests of various locations along the luminal surface of the main pulmonary artery using the stimulation system are conducted so as to identify a preferred location for the electrodes, as discussed herein.
  • the stimulation system can be used to initiate and adjust the parameters of the stimulation electrical energy. Such parameters include, but are not limited to, terminating, increasing, decreasing, or changing the rate or pattern of the stimulation electrical energy.
  • the stimulation system can also deliver stimulation electrical energy that are episodic, continuous, phasic, in clusters, intermittent, upon demand by the patient or medical personnel, or preprogrammed to respond to a signal, or portion of a signal, sensed from the patient.
  • the stimulation electrical energy can have a voltage of about 0.1 microvolts to about 75 volts (V), where voltage values of 1 V to 50 V, or 0.1 V to 10 V are also possible.
  • the stimulation electrical energy can be delivered at a frequency of about 1 Hertz (Hz) to about 100,000 Hz, where frequency values of about 2 Hz to about 200 Hz are also possible.
  • the stimulation electrical energy can have a pulse width of about 100 microseconds to about 100 milliseconds.
  • the stimulation electrical energy can also have a variety of wave forms, such as for example, square wave, biphasic square wave, sine wave, or other electrically safe and feasible combinations.
  • the stimulation electrical energy may be applied to multiple target sites simultaneously or sequentially.
  • An open-loop or closed-loop feedback mechanism may be used in conjunction with the present disclosure.
  • a professional can monitor cardiac parameters and changes to the cardiac parameters of the patient. Based on the cardiac parameters the professional can adjust the parameters of the stimulation electrical energy applied to autonomic cardiopulmonary fibers.
  • cardiac parameters monitored include arterial blood pressure, central venous pressure, capillary pressure, systolic pressure variation, arterial blood gases, cardiac output, systemic vascular resistance, pulmonary artery wedge pressure, gas composition of the patient's exhaled breath and/or mixed venous oxygen saturation.
  • Cardiac parameters can be monitored by an electrocardiogram, invasive hemodynamics, an echocardiogram, or blood pressure measurement or other devices known in the art to measure cardiac function. Other parameters such as body temperature and respiratory rate can also be monitored and processed as part of the feedback mechanism.
  • the cardiac parameters of the patient are received and processed by the stimulation system, as discussed herein, where the parameters of the stimulation electrical energy are adjusted based at least in part on the cardiac parameters.
  • a sensor is used to detect a cardiac parameter and generate a sensor signal.
  • the sensor signal is processed by a sensor signal processor, which provides a control signal to a signal generator.
  • the signal generator in turn, can generate a response to the control signal by activating or adjusting one or more of the parameters of the stimulation electrical energy applied by the catheter to the patient.
  • the control signal can initiate, terminate, increase, decrease or change the parameters of the stimulation electrical energy.
  • the one or more electrodes of the catheter may be used as a sensor a recording electrode. When necessary these sensing or recording electrodes may delivery stimulation therapy as discussed herein.
  • the stimulation system can also monitor to determine if the one or more electrodes have dislodged from their position within the main pulmonary artery and/or one or both of the pulmonary arteries (the right pulmonary artery and the left pulmonary artery). For example, the stimulation system can monitor the voltage levels of the stimulation electrical energy delivered and received by the one or more electrodes once the catheter is implanted. If the voltage levels received by the one or more electrode change by a predetermined percentage, a warning signal is produced by the stimulation system and the stimulation electrical energy is stopped.
  • the stimulation system 12600 includes an input/output connector 12602 that releasably joins the conductive elements of the catheter of the present disclosure. It is also possible that the conductive elements are permanently coupled to the stimulation system (e.g., not releasably coupled). An input from the sensor can also be releasably coupled to the input/output connector 12602 so as to receive the sensor signal(s) discussed herein.
  • the input/output connector 12602 is connected to an analog to digital converter 12604 .
  • the output of the analog to digital converter 12604 is connected to a microprocessor 12606 through a peripheral bus 12608 including address, data and control lines.
  • Microprocessor 12606 can process the sensor data, when present, in different ways depending on the type of sensor in use.
  • the microprocessor 12606 can also control, as discussed herein, the pulse control output generator 12610 that delivers the stimulation electrical energy to the one or more electrodes via the input/output connector 12602 .
  • the parameters of the stimulation electrical energy can be controlled and adjusted, as needed, by instructions programmed in a memory 12612 and executed by a programmable pulse generator 12613 .
  • the instructions in memory 12612 for the programmable pulse generator 12613 can be set and/or modified based on input from the closed-looped system, via the microprocessor 12606 .
  • the instructions in memory 12612 for the programmable pulse generator 12613 can also be set and/or modified through inputs from a professional via an input 12614 connected through the peripheral bus 12608 . Examples of such an input include a keyboard with a display screen or through a touch screen (not shown), as are known.
  • the stimulation system 12600 can also include a communications port 12615 that connects to the peripheral bus 12608 , where data and/or programming instructions can be received by the microprocessor 12606 and/or the memory 12612 .
  • the stimulation system 12600 can also include a power source 12616 .
  • the power source 12616 can be a battery or a power source supplied from an external power supply (e.g., an AC/DC power converter coupled to an AC source).
  • the programmable pulse generator 12612 can also include a housing 12618 .
  • the microprocessor 12606 can execute one or more algorithms in order to provide stimulation with closed loop feedback control.
  • the microprocessor 12606 can also be controlled by a professional via the input 12614 to initiate, terminate and/or change (e.g., adjust) the parameters of the stimulation electrical energy.
  • the closed loop feedback control can be used to help maintain one or more of a patient's cardiac parameters at or within a threshold value or range programmed into memory 12612 . For example, under closed loop feedback control measured cardiac parameter value(s) can be compared and then it can be determine whether or not the measured value(s) lies outside a threshold value or a pre-determined range of values.
  • the closed loop feedback control continues to monitor the cardiac parameter value(s) and repeats the comparison on a regular interval. If, however, the cardiac parameter value(s) from a sensor indicate that one or more cardiac parameters are outside of the threshold value or the pre-determined range of values one or more of the parameters of the stimulation electrical energy will be adjusted by the microprocessor 12606 .
  • the adjustments can be made using process control logic (e.g., fuzzy logic, negative feedback, etc.) so as to maintain control of the pulse control output generator 12610 .

Abstract

Embodiments of the present disclosure provide for catheters for use in electrical neuromodulation. The catheter of the present disclosure includes an elongate body having a first end and a second end. The elongate body includes a longitudinal center axis that extends between the first end and the second end. The elongate body further includes three or more surfaces that define a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis. The catheter further includes one or more electrodes on one surface of the three or more surfaces of the elongate body, where conductive elements extend through the elongate body. The conductive elements can conduct electrical current to combinations of the one or more electrodes.

Description

    TECHNICAL FIELD
  • The present disclosure relates generally to catheters, and more particularly to catheter and electrode systems for use in electrical neuromodulation.
  • BACKGROUND
  • Acute heart failure is a cardiac condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. The condition impairs quality of life and is a leading cause of hospitalizations and mortality in the western world. Treating acute heart failure is typically aimed at removal of precipitating causes, prevention of deterioration in cardiac function, and control of the patient's congestive state.
  • Treatments for acute heart failure include the use of inotropic agents, such as dopamine and dobutamine. These agents, however, have both chronotropic and inotropic effects and characteristically increase heart contractility at the expense of significant increments in oxygen consumption secondary to elevations in heart rate. As a result, although these inotropic agents increase myocardial contractility and improve hemodynamics, clinical trials have consistently demonstrated excess mortality caused by cardiac arrhythmias and increase in the myocardium consumption.
  • As such, there is a need for selectively and locally treating acute heart failure and otherwise achieving hemodynamic control without causing unwanted systemic effects.
  • SUMMARY
  • Embodiments of the present disclosure provide for catheter and electrode systems for use in electrical neuromodulation. The catheter and electrode systems of the present disclosure, for example, may be useful in electrical neuromodulation of patients with cardiac disease, such as patients with chronic cardiac disease. As discussed herein, the configuration of the catheter and electrode systems of the present disclosure allows for a portion of the catheter to be positioned within the vasculature of the patient in the main pulmonary artery and/or one or both of the pulmonary arteries (the right pulmonary artery and/or the left pulmonary artery). Once positioned, the catheter and electrode systems of the present disclosure can provide electrical energy to stimulate the autonomic nerve fibers surrounding the main pulmonary artery and/or one or both of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient.
  • In a first example, the catheter of the present disclosure includes an elongate body having a first end and a second end. The elongate body includes a longitudinal center axis that extends between the first end and the second end. The elongate body further includes three or more surfaces that define a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis. The catheter further includes one or more, but preferably two or more, electrodes on one surface of the three or more surfaces of the elongate body, where conductive elements extend through the elongate body. The conductive elements can conduct electrical current to combinations of the one or more electrodes or in the instance of a single electrode a second electrode is provided elsewhere in the system for flow of current.
  • By way of example for the first embodiment, the surfaces defining the convex polygonal cross-sectional shape of the elongate body can be a rectangle. Other shapes are possible. In one embodiment, the one or two or more electrodes are only on the one surface of the three or more surfaces of the elongate body. The one or more electrodes can have an exposed face that is co-planar with the one surface of the three or more surfaces of the elongate body. The one surface of the three or more surfaces of the elongate body can further include anchor structures that extend above the one surface. In addition to the surfaces defining the convex polygonal cross-sectional shape, the elongate body of the catheter can also have a portion with a circular cross-section shape taken perpendicularly to the longitudinal center axis.
  • The catheter of the present embodiment can also include an inflatable balloon on a peripheral surface of the elongate body. The inflatable balloon includes a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume. An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon.
  • In a second example, the catheter of the present disclosure includes an elongate body having a peripheral surface and a longitudinal center axis extending between a first end and a second end. The elongate body of this second example has an offset region defined by a series of predefined curves along the longitudinal center axis. The predefined curves include a first portion having a first curve and a second curve in the longitudinal center axis, a second portion following the first portion, where the second portion has a zero curvature (e.g., a straight portion), and a third portion following the second portion, the third portion having a third curve and a fourth curve. An inflatable balloon is positioned on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume. An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon. One or more electrodes are positioned on the elongate body along the second portion of the offset region of the elongate body. Conductive elements extend through the elongate body, where the conductive elements conduct electrical current to combinations of the one or more electrodes.
  • The portions of the elongate body of this second example can have a variety of shapes. For example, the second portion of the elongate body can form a portion of a helix. The elongate body can also have three or more surfaces defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis, where the one or more electrodes are on one surface of the three or more surfaces of the elongate body. For this embodiment, the convex polygonal cross-sectional shape can be a rectangle. The one or more electrodes are only on the one surface of the three or more surfaces of the elongate body. The one or more electrodes can have an exposed face that is co-planar with the one surface of the three or more surfaces of the elongate body.
  • In a third example, the catheter of the present disclosure includes an elongate body with a peripheral surface and a longitudinal center axis extending between a first end and a second end. The elongate body includes a surface defining a deflection lumen, where the deflection lumen includes a first opening and a second opening in the elongate body. An inflatable balloon is located on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume. An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon. One or more electrodes are located on the elongate body, where the second opening of the deflection lumen is opposite the one or more electrodes on the elongate body. Conductive elements extend through the elongate body, where the conductive elements conduct electrical current to combinations of the one or more electrodes. The catheter also includes an elongate deflection member, where the elongate deflection member extends through the second opening of the deflection lumen in a direction opposite the one or more electrodes on one surface of the elongate body.
  • In a fourth example, the catheter of the present disclosure can include an elongate body having a peripheral surface and a longitudinal center axis extending between a first end and a second end. The elongate body includes a surface defining an electrode lumen, where the electrode lumen includes a first opening in the elongate body. The catheter further includes an inflatable balloon on the peripheral surface of the elongate body, the inflatable balloon having a balloon wall with an interior surface that along with a portion of the peripheral surface of the elongate body defines a fluid tight volume. An inflation lumen extends through the elongate body, the inflation lumen having a first opening into the fluid tight volume of the inflatable balloon and a second opening proximal to the first opening to allow for a fluid to move in the fluid tight volume to inflate and deflate the balloon. The catheter further includes an elongate electrode member, where the elongate electrode member extends through the first opening of the electrode lumen of the elongate body, where the electrode member includes one or more electrodes and conductive elements extending through the electrode lumen, where the conductive elements conduct electrical current to combinations of the one or more electrodes.
  • The elongate electrode member can form a loop that extends away from the peripheral surface of the elongate body. The elongate electrode member forming the loop can be in a plane that is co-linear with the longitudinal center axis of the elongate body. Alternatively, the elongate electrode member forming the loop is in a plane that is perpendicular to the longitudinal center axis of the elongate body.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 2 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 3 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 4 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 5 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 6 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 7 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 8 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 9 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 10 provides an illustration of an embodiment of the catheter according to the present disclosure.
  • FIG. 11 provides an illustration of a main pulmonary artery of a heart.
  • FIG. 12 provides an illustration of a stimulation system for use with the catheter of the present system.
  • DETAILED DESCRIPTION
  • Embodiments of the present disclosure provide for a catheter and electrode systems for use in electrical neuromodulation. The catheter and electrode systems of the present disclosure, for example, may be useful in electrical neuromodulation of patients with cardiac disease, such as patients with chronic cardiac disease. As discussed herein, the configuration of the catheter and electrode systems of the present disclosure allows for a portion of the catheter and electrode systems to be positioned within the vasculature of the patient in the main pulmonary artery and at least one of the pulmonary arteries (the right pulmonary artery and/or the left pulmonary artery). Once positioned, the catheter and electrode systems of the present disclosure can be used to provide electrical energy to stimulate the autonomic nerve fibers surrounding the main pulmonary artery and/or one of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient.
  • The Figures herein follow a numbering convention in which the first digit or digits correspond to the drawing Figure number and the remaining digits identify an element or component in the drawing. Similar elements or components between different Figures may be identified by the use of similar digits. For example, 110 may reference element “10” in FIG. 1, and a similar element may be referenced as 210 in FIG. 2. As will be appreciated, elements shown in the various embodiments herein can be added, exchanged, and/or eliminated so as to provide any number of additional embodiments of the present disclosure.
  • The terms “distal” and “proximal” are used in the following description with respect to a position or direction relative to the treating clinician taken along the catheter of the present disclosure. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician taken along the catheter of the present disclosure.
  • The catheters and electrode systems provided herein includes one or more electrodes, but preferably two or more electrodes, as discussed herein. It is understood that the phrase one or more electrodes can be replaced herein with two or more electrodes if desired.
  • Referring to FIG. 1, there is shown a perspective view of a catheter 100 according one example of the present disclosure. The catheter 100 includes an elongate body 102 having a first end 104 and a second end 106 distal from the first end 104. As illustrated, the elongate body 102 includes a longitudinal center axis 108 extending between the first end 104 and the second end 106 of the elongate body 102. The elongate body 102 also includes a portion 110 that has three or more surfaces 112 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 108.
  • As used herein, the convex polygonal cross-sectional shape of the elongate body 102 includes those shapes for which every internal angle is less than 180 degrees and where every line segment between two vertices of the shape remains inside or on the boundary of the shape. Examples of such shapes include, but are not limited to, triangular, rectangular (as illustrated in FIG. 1), square, pentagon and hexagon, among others.
  • Catheter 100 further includes one or more, preferably two or more, electrodes 114 on one surface of the three or more surfaces 112 of the elongate body 102. Conductive elements 116 extend through the elongate body 102, where the conductive elements 116 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 114. Each of the one or more electrodes 114 is coupled to a corresponding conductive element 116. The conductive elements 116 are electrically isolated from each other and extend through the elongate body 102 from each respective electrode 114 through the first end 104 of the elongate body 102. The conductive elements 116 terminate at a connector port, where each of the conductive elements 116 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 116 are permanently coupled to the stimulation system (e.g., not releasably coupled). The stimulation system can be used to provide stimulation electrical energy that is conducted through the conductive elements 116 and delivered across combinations of the one or more electrodes 114. The one or more electrodes 114 are electrically isolated from one another, where the elongate body 102 is formed of an electrically insulating material as discussed herein. As illustrated, the one or more electrodes 114 can be located only on the one surface of the three or more surfaces 112 of the elongate body 102.
  • There can be a variety of the number and the configuration of the one or more electrodes 114 on the one surface of the three or more surfaces 112 of the elongate body 102. For example, as illustrated, the one or more electrodes 114 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location. As discussed herein, the one or more electrodes 114 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 114. So, for example, the electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other. For example, the electrodes in the array of electrodes can have a column and row configuration (as illustrated in FIG. 1). Alternatively, the electrodes in the array of electrodes can have a concentric radial pattern, where the electrodes are positioned so as to form concentric rings of the electrodes. Other patterns are possible, where such patterns can either be repeating patterns or random patterns.
  • As illustrated, the one or more electrodes 114 have an exposed face 118. The exposed face 118 of the electrode 114 provides the opportunity for the electrode 114, when implanted in the patient, to be placed into proximity and/or in contact with the vascular tissue of the patient, as opposed to facing into the volume of blood in the artery. As the one or more electrodes 114 are located on one surface of the three or more surfaces 112 of the elongate body 102, the electrodes 114 can be placed into direct proximity to and/or in contact with the tissue of any combination of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery.
  • By locating the one or more electrodes 114 on the one surface of the three or more surfaces 112, the exposed face 118 of the electrode can be positioned inside the patient's vasculature to face and/or contact the tissue of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery. When the one or more electrodes 114 are in contact with luminal surface of the patient's vasculature, the one or more electrodes 114 will be pointing away from the majority of the blood volume of that region of the pulmonary artery. This allows the electrical pulses from the one or more electrodes 114 to be directed into the tissue adjacent the implant location, instead of being directed into the blood volume.
  • The exposed face 118 of the one or more electrodes 114 can have a variety of shapes. For example, the exposed face 118 can have a flat planar shape. In this embodiment, the exposed face 118 of the electrodes 114 can be co-planar with the one surface of the three or more surfaces 112 of the elongate body 102. In an alternative embodiment, the exposed face 118 of the electrodes 114 can have a semi-hemispherical shape. Other shapes for the exposed face 118 of the electrodes 114 can include semi-cylindrical, wave-shaped, and zig-zag-shaped. The exposed face 118 of the electrodes 114 can also include one or more anchor structures. Examples of such anchor structures include hooks that can optionally include a barb. Similarly, the electrodes can be shaped to also act as anchor structures.
  • In an additional embodiment, the one surface of the three or more surfaces 112 of the elongate body 102 that include the exposed face 118 of the one or more electrodes 114 can further include anchor structures 120 that extend above the one surface of the three or more surfaces 112. As illustrated, the anchor structures 120 can include portions that can contact the vascular tissue in such a way that the movement of the one or more electrodes 114 at the location where they contact the vascular tissue is minimized. The anchor structures 120 can have a variety of shapes that may help to achieve this goal. For example, the anchor structures 120 can have a conical shape, where the vertex of the conical shape can contact the vascular tissue. In an additional embodiment, the anchor structures 120 can have a hook configuration (with or without a barb).
  • As illustrated, the elongate body 102 of catheter 100 can also include a portion 122 with a circular cross-section shape taken perpendicularly to the longitudinal center axis 108. The elongate body 102 of catheter 100 also includes a surface 124 defining a guide-wire lumen 126 that extends through the elongate body 102. The guide-wire lumen 126 has a diameter that is sufficiently large to allow the guide wire to freely pass through the guide-wire lumen 126. The guide-wire lumen 126 can be positioned concentrically relative the longitudinal center axis 108 of the elongate body 102.
  • Alternatively, and as illustrated in FIG. 1, the guide-wire lumen 126 is positioned eccentrically relative the longitudinal center axis 108 of the elongate body 102. When the guide-wire lumen 126 is positioned eccentrically relative the longitudinal center axis 108 the guide-wire lumen 126 will have a wall thickness 128 taken perpendicularly to the longitudinal center axis that is greater than a wall thickness 130 of a remainder of the catheter taken perpendicularly to the longitudinal center axis. For this configuration, the differences in wall thickness 128 and 130 help to provide the elongate body 102 with a preferential direction in which to bend. For example, the wall thickness 128 of the elongate body 102 being greater than the wall thickness 130 will cause the side of the elongate body 102 with the greater wall thickness to preferentially have the larger radius of curvature when the elongate body 102 bends. By positioning the exposed face 118 of the electrodes 114 on the side of the elongate body 102 having the great wall thickness (e.g., wall thickness 128), the one or more electrodes 114 can be more easily and predictably brought into contact with the luminal surface of the vasculature in and around the main pulmonary artery and at least one of the pulmonary arteries.
  • The catheter 100 shown in FIG. 1 can be positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. To accomplish this, a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision and guided to the right ventricle using known techniques. For example, the pulmonary artery guide catheter can be inserted into the vasculature via a peripheral vein of the arm (e.g., as with a peripherally inserted central catheter). Other approaches can include, but are not limited to, an Internal Jugular approach, as is known. Changes in a patient's electrocardiography and/or pressure signals from the vasculature can be used to guide and locate the pulmonary artery guide catheter within the patient's heart. Once in the proper location, a guide wire can be introduced into the patient via the pulmonary artery guide catheter, where the guide wire is advanced into the main pulmonary artery and/or one of the pulmonary arteries. Using the guide-wire lumen 126, the catheter 100 can be advanced over the guide wire so as to position the catheter 100 in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. Various imaging modalities can be used in positioning the guide wire of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • Using a stimulation system, as discussed herein, stimulation electrical energy can be delivered across combinations of one or more of the electrodes 114. It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • FIG. 2 provides an additional embodiment of the catheter 200 as provided herein. The catheter 200 includes the features and components as discussed above, a discussion of which is not repeated but the element numbers are included in FIG. 2 with the understanding that the discussion of these elements is implicit. In addition, the elongate body 202 of the catheter 200 includes a serpentine portion 232 proximal to the one or more electrodes 214. When implanted in the vasculature of the patient, the serpentine portion 232 of the elongate body 202 can act as a “spring” to absorb and isolate the movement of the one or more electrodes 214 from the remainder of the elongate body 202 of the catheter 200. Besides having a serpentine shape, the serpentine portion 232 can have a coil like configuration. Other shapes that achieve the objective of absorbing and isolating the movement of the one or more electrodes 214 from the remainder of the elongate body 202 of the catheter 200 once implanted are possible. During delivery of the catheter 200, the presences of the guide wire in the guide-wire lumen 226 can help to temporarily straighten the serpentine portion 232 of the elongate body 202.
  • Referring now to FIG. 3 there is shown an additional embodiment of the catheter 300 as provided herein. The catheter 300 can include the features and components as discussed above for catheters 100 and/or 200, a discussion of which is not repeated but the element numbers are included in FIG. 3 with the understanding that the discussion of these elements is implicit. In addition, the catheter 300 of the present embodiment includes an inflatable balloon 334. As illustrated, the elongate body 302 includes a peripheral surface 336, where the inflatable balloon 334 is located on the peripheral surface 336 of the elongate body 302. The inflatable balloon 334 includes a balloon wall 338 with an interior surface 340 that along with a portion 342 of the peripheral surface 336 of the elongate body 302 defines a fluid tight volume 344.
  • The elongate body 302 further includes a surface 345 that defines an inflation lumen 346 that extends through the elongate body 302. The inflation lumen 346 includes a first opening 348 into the fluid tight volume 344 of the inflatable balloon 334 and a second opening 350 proximal to the first opening 348 to allow for a fluid to move in the fluid tight volume 344 to inflate and deflate the balloon 334. A syringe, or other known devices, containing the fluid (e.g., saline or a gas (e.g., oxygen)) can be used to inflate and deflate the balloon 334.
  • The catheter 300 shown in FIG. 3 can positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. As discussed herein, a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision, and guided to the right ventricle using known techniques. Once in the proper location, the balloon 334 can be inflated, as described, to allow the catheter 300 to be carried by the flow of blood from the right ventricle to the main pulmonary artery and/or one of the pulmonary arteries. Additionally, various imaging modalities can be used in positioning the catheter of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • The catheter 300 can be advance along the main pulmonary artery until the second end 306 of the catheter 300 contacts the top of the main pulmonary artery (e.g., a location distal to the pulmonary valve and adjacent to both the pulmonary arteries). Once the second end 306 of the catheter 300 reaches the top of the main pulmonary artery the pulmonary artery guide catheter can be moved relative the catheter 300 so as to deploy the catheter 300 from the pulmonary artery guide catheter.
  • Markings can be present on the peripheral surface of the catheter body 302, where the markings start and extend from the first end 302 towards the second end 306 of the catheter body 302. The distance between the markings can be of units (e.g., millimeters, inches, etc.), which can allow the length between the second end 306 of the catheter 300 and the top of the main pulmonary artery to be determined.
  • The ability to measure this distance from the top of the main pulmonary artery may be helpful in placing the one or more electrodes 314 in a desired location within the main pulmonary artery. In addition to measuring the distance from which the second end 306 of the elongate body 302 is placed from the top of the main pulmonary artery, the elongate body 302 can also be used to identify, or map, an optimal position for the one or more electrodes 314 within the vasculature. For example, the second end 306 of the elongate body 302 can be positioned at the desired distance from the top of the main pulmonary artery using the markings on the peripheral surface of the catheter body 302.
  • Using the stimulation system, as discussed herein, stimulation electrical energy can be delivered across combinations of the one or more electrodes 314. It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • Referring now to FIG. 4 there is shown an additional embodiment of the catheter 400 as according to the present disclosure. The catheter 400 can include the features and components as discussed above for catheters 100, 200 and/or 300, a discussion of which is not repeated but the element numbers are included in FIG. 4 with the understanding that the discussion of these elements is implicit. In addition, the catheter 400 of the present embodiment includes a surface 452 defining a deflection lumen 454. The deflection lumen 454 includes a first opening 456 and a second opening 458 in the elongate body 402. In one embodiment, the second opening 458 can be opposite the one or more electrodes 414 on one surface of the three or more surfaces 412 of the elongate body 402.
  • The catheter 400 further includes an elongate deflection member 460. The elongate deflection member 460 includes an elongate body 461 having a first end 463 and a second end 465. The elongate deflection member 460 extends through the first opening 456 to the second opening 458 of the deflection lumen 454. The deflection lumen 454 has a size (e.g., a diameter) sufficient to allow the deflection member 460 to pass through the deflection lumen 454 with the first end 463 of the deflection member 460 proximal to the first end 404 of the elongate body 402 and the second end 465 of the deflection member 460 extendable from the second opening 458 of the deflection lumen 454. Pressure applied from the first end 463 of the deflection member 460 can cause the deflection member 460 to move within the deflection lumen 454. For example, when pressure is applied to the deflection member 460 to move the first end 463 of the deflection member 460 towards the first opening 456 of the deflection lumen 454, the pressure causes the second end 465 of the deflection member 460 to extend from the second opening 458.
  • As generally illustrated, the elongate deflection member 460 can be advanced through the deflection lumen 454 so that elongate deflection member 460 extends laterally away from the one or more electrodes 414 on the one surface of the three or more surfaces 412 of the elongate body 402. The elongate deflection member 460 can be of a length and shape that allows the elongate deflection member 460 to be extended a distance sufficient to bring the one or more electrodes 414 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures. Optionally, the elongate deflection member 460 can be configured to include one or more of the electrode 414, as discussed herein.
  • For the various embodiments, the elongate body 461 of the deflection member 460 is formed of a flexible polymeric material. Examples of such flexible polymeric material include, but are not limited to, medical grade polyurethanes, such as polyester-based polyurethanes, polyether-based polyurethanes, and polycarbonate-based polyurethanes; polyamides, polyamide block copolymers, polyolefins such as polyethylene (e.g., high density polyethylene); and polyimides, among others.
  • In an additional embodiment, the elongate body 461 of the elongate deflection member 460 can also include one or more support wires. The support wires can be encased in the flexible polymeric material of the elongate body 461, where the support wires can help to provide both column strength and a predefined shape to the elongate deflection member 460. For example, the support wires can have a coil shape that extends longitudinally along the length of the elongate body 461. The coil shape allows for the longitudinal force applied near or at the first end 463 of the deflection member 460 to be transferred through the elongate body 461 so as to laterally extend the second end 465 of the deflection member 460 from the second opening 458 of the deflection lumen 454.
  • The support wires can also provide the deflection member 460 with a predetermined shape upon laterally extending from the second opening 458 of the deflection lumen 454. The predetermined shape can be determined to engage the luminal wall of the pulmonary artery in order to bring the electrodes 414 into contact with the vascular tissue. The predetermined shape and the support wires can also help to impart stiffness to the deflection member 460 that is sufficient to maintain the electrodes 414 on the luminal wall of the pulmonary artery under the conditions within the vasculature of the patient.
  • The support wires can be formed of a variety of metals or metal alloys. Examples of such metals or metal alloys include surgical grade stainless steel, such as austenitic 316 stainless among others, and the nickel and titanium alloy known as Nitinol. Other metals and/or metal alloys, as are known, can be used.
  • The catheter 400 shown in FIG. 4 can positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. As discussed herein, a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision, and guided to the right ventricle using known techniques. Once in the proper location, the balloon 434 can be inflated, as described, to allow the catheter 400 to be carried by the flow of blood from the right ventricle to the main pulmonary artery and/or one of the pulmonary arteries. Additionally, various imaging modalities can be used in positioning the catheter of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • The catheter 400 can be advance along the main pulmonary artery until the second end 406 of the catheter 400 contacts the top of the main pulmonary artery (e.g., a location distal to the pulmonary valve and adjacent to both the pulmonary arteries). Once the second end 406 of the catheter 400 reaches the top of the main pulmonary artery the pulmonary artery guide catheter can be moved relative the catheter 400 so as to deploy the catheter 400 from the pulmonary artery guide catheter.
  • Markings, as discussed herein, can be present on the peripheral surface of the catheter body 402 that can assist in positioning the catheter 400 within the main pulmonary artery. The ability to measure this distance from the top of the main pulmonary artery may be helpful in placing the one or more electrodes 414 in a desired location within the main pulmonary artery. In addition to measuring the distance from which the second end 406 of the elongate body 402 is placed from the top of the main pulmonary artery, the elongate body 402 can also be used to identify, or map, an optimal position for the one or more electrodes 414 within the vasculature. For example, the second end 406 of the elongate body 402 can be positioned at the desired distance from the top of the main pulmonary artery using the markings on the peripheral surface of the catheter body 402.
  • When desired, the elongate deflection member 460 can be extended laterally from the elongate body 402 to a distance sufficient to cause the one surface of the three or more surfaces 412 of the elongate body 402 having the one or more electrodes to contact a surface of the main pulmonary artery, such as the anterior surface of the main pulmonary artery, and thereby bring the one or more electrodes 414 into contact with the main pulmonary artery or one of the pulmonary arteries (the left pulmonary artery or the right pulmonary artery). The elongate deflection member 460, as will be appreciated, biases and helps to place the one or more electrodes 414 along the vessel surface (e.g., along the posterior surface of the main pulmonary artery or one of the pulmonary arteries (the left pulmonary artery or the right pulmonary artery)).
  • Due to its adjustable nature (e.g., how much pressure is applied to the elongate deflection member 460), the elongate deflection member 460 can be used to bring the one or more electrodes 414 into contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries with a variety of pressures. So, for example, the elongate deflection member 460 can bring the one or more electrodes 414 into contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries with a first pressure. Using the stimulation system, as discussed herein, stimulation electrical energy can be delivered across combinations of the one or more electrodes 414 in the electrode array. It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests.
  • It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • If necessary, the distance the elongate deflection member 460 extends laterally from the elongate body 402 can be changed (e.g., made shorter) to allow the elongate body 402 to be rotated in either a clockwise or counter-clockwise direction, thereby repositioning the one or more electrodes 414 in contact with the luminal surface of the main pulmonary artery or one of the pulmonary arteries. The stimulation system can again be used to deliver stimulation electrical energy across combinations of one or more of the electrodes 414 in the electrode array. The patient's cardiac response to this subsequent test can then be monitored and recorded for comparison to previous and subsequent test. In this way, a preferred location for the position of the one or more electrodes 414 along the luminal surface of the main pulmonary artery or one of the pulmonary arteries can be identified. Once identified, the elongate deflection member 460 can be used to increase the lateral pressure applied to the one or more electrodes, thereby helping to better anchor the catheter 400 in the patient.
  • Referring now to FIG. 5, there is shown an additional embodiment of a catheter 562. The catheter 562 includes an elongate body 502 having a peripheral surface 536 and a longitudinal center axis 508 extending between a first end 504 and a second end 506. The catheter 562 can include the features and components as discussed above for catheters 100, 200, 300 and/or 400, a discussion of which is not repeated but the element numbers are included in FIG. 5 with the understanding that the discussion of these elements is implicit.
  • The catheter 562 of the present embodiment includes an inflatable balloon 534. As illustrated, the elongate body 502 includes a peripheral surface 536, where the inflatable balloon 534 is located on the peripheral surface 536 of the elongate body 502. The inflatable balloon 534 includes a balloon wall 538 with an interior surface 540 that along with a portion 542 of the peripheral surface 536 of the elongate body 502 defines a fluid tight volume 544.
  • The elongate body 502 further includes a surface 545 that defines an inflation lumen 546 that extends through the elongate body 502. The inflation lumen 546 includes a first opening 548 into the fluid tight volume 544 of the inflatable balloon 534 and a second opening 550 proximal to the first opening 548 to allow for a fluid to move in the fluid tight volume 544 to inflate and deflate the balloon 534. A syringe, or other known devices, containing the fluid (e.g., saline or a gas (e.g., oxygen)) can be used to inflate and deflate the balloon 534.
  • The elongate body 502 further includes an offset region 564 defined by a series of predefined curves along the longitudinal center axis 508. As used herein, “predefined curves” are curves formed in the elongate body 502 during the production of the catheter 562, where when deformed such curves provide a spring like force to return to their pre-deformation shape (i.e., their original shape). As illustrated, the series of predefined curves includes a first portion 566 that has a first curve 568 in the longitudinal center axis 508 followed by a second curve 570 in the longitudinal center axis 508 of the elongate body 502. The length and degree of each of the first curve 568 and second curve 570, along with the distance between such curves helps to define the height of the offset region 564. As discussed herein, the height of the offset region 564 can be determined by the inner diameter of one or more locations along the main pulmonary artery and/or one of the pulmonary arteries.
  • The first portion 566 of the elongate body 502 is followed by a second portion 572 of the elongate body 502. The longitudinal center axis 508 along the second portion 572 can have a zero curvature (i.e., a straight line), as illustrated in FIG. 5. The second portion 572 of the elongate body 502 is followed by a third portion 574 of the elongate body 502. The longitudinal center axis 508 transitions from the second portion 572 along a third curve 576, which then transitions into a fourth curve 578. As illustrated, after the fourth curve 578, the longitudinal center axis 508 is approximately co-linear with the longitudinal center axis 508 leading up to the first curve 568. It is noted that the curves of the first portion 566 and the second portion 574 can also all be in approximately the same plane. It is, however, possible that the curves of the first portion 566 and the second portion 574 are not in the same plane. For example, when the curves of the first portion 566 and the second portion 574 are not in the same plane the longitudinal center axis 508 can include a helical curve through these portions of the elongate body 502. Other shapes are possible.
  • The elongate body 502 can further include one or more electrodes 514, as discussed herein, along the second portion 572 of the offset region 564 of the elongate body 502. As illustrated, the one or more electrodes 514 can be on the surface of the elongate body 502 in the second portion 572 of the offset region 564. Conductive elements 516 extend through the elongate body 502, where the conductive elements 516 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 514. Each of the one or more electrodes 514 is coupled to a corresponding conductive element 516. The conductive elements 516 are electrically isolated from each other and extend through the elongate body 502 from each respective electrode 514 through the first end 504 of the elongate body 502. The conductive elements 516 terminate at a connector port, where each of the conductive elements 516 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 516 are permanently coupled to the stimulation system (e.g., not releasably coupled). The stimulation system can be used to provide stimulation electrical energy that is conducted through the conductive elements 516 and delivered across combinations of the one or more electrodes 514. The one or more electrodes 514 are electrically isolated from one another, where the elongate body 502 is formed of an electrically insulating material as discussed herein.
  • There can be wide variety for the number and configuration of the one or more electrodes 514 on the one surface of the second portion 572 of the elongate body 502. For example, as illustrated, the one or more electrodes 514 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location. As discussed herein, the one or more electrodes 514 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 514. The electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other. So, for example, the electrodes in the array of electrodes can have a column and row configuration. Alternatively, the electrodes in the array of electrodes can have a concentric radial pattern, where the electrodes are positioned so as to form concentric rings of the electrodes. Other patterns are possible, where such patterns can either be repeating patterns or random patterns. As discussed herein, the catheter 562 further includes conductive elements 516 extending through the elongate body, where the conductive elements 516 conduct electrical current to combinations of the one or more electrodes 514.
  • As discussed herein, the length and degree of each of the curves, along with the distance between such curves, helping to define the first portion 566 and the third portion 574 of the longitudinal center axis 508 helps to define the relative height of the offset region 564. For the various embodiments, the height of the offset region 564 can be determined by the inner diameter of one or more locations along the main pulmonary artery and/or one of the pulmonary arteries. In this way the first portion 566 and the third portion 574 can bring the second portion 572 and the one or more electrodes 514 on the surface of the elongate body 502 into contact with the vascular wall of the patient in the main pulmonary artery and/or one of the pulmonary arteries. In other words, the transitions of the first portion 566 and the third portion 574 of the elongate body 502 in the offset region 564 can act to bias the second portion 572 and the one or more electrodes 514 against the vascular wall of the patient in the main pulmonary artery and/or one of the pulmonary arteries.
  • The elongate body 502 further includes a surface 524 defining a guide-wire lumen 526 that extends through the elongate body 502. As provided herein, the guide-wire lumen 526 can be concentric relative the longitudinal center axis 508 of the elongate body 502 (as illustrated in FIG. 5). Alternatively, the guide-wire lumen 526 can be eccentric relative the longitudinal center axis 508 of the elongate body 502. As discussed herein, the guide-wire lumen 526 can have a wall thickness 528 that is greater than a wall thickness 530 of a remainder of the catheter 562 taken perpendicularly to the longitudinal center axis 508. In an additional embodiment,
  • a portion of the elongate body 502 includes a serpentine portion, as discussed and illustrated herein, proximal to the one or more electrodes 514.
  • For the present embodiment, a guide-wire used with the catheter 562 can serve to temporarily “straighten” the offset region 564 when the guide-wire is present in the guide-wire lumen 526 that passes along the offset region 564. Alternatively, the guide-wire can be used to impart the shape of the offset region 564 to the catheter 562. In this embodiment, the elongate body 502 of the catheter 562 can have a straight shape (e.g., no predefined lateral shape). To impart the offset region 564 the guide wire is “shaped” (e.g., bent) to the desired configuration of the offset region at point that corresponds to the desired longitudinal location for the offset region on the elongate body 502. The offset region 564 of the catheter 562 can be provided by inserting the guide wire with the predefined lateral shape.
  • In FIG. 5 the catheter 562 of the present embodiment further includes a surface 552 defining a deflection lumen 554, as discussed herein. The catheter 562 further includes an elongate deflection member 560, also as discussed herein. As generally illustrated, the elongate deflection member 560 can be advanced through the deflection lumen 554 so that elongate deflection member 560 extends laterally away from the one or more electrodes 514 on the second portion 572 of the elongate body 502. The elongate deflection member 560 can be of a length and shape that allows the elongate deflection member 560 to be extended a distance sufficient to bring the one or more electrodes 514 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures.
  • In an additional embodiment, the elongate body 561 of the elongate deflection member 560 can also include one or more support wires 581. The support wires 581 can be encased in the flexible polymeric material of the elongate body 561, where the support wires 581 can help to provide both column strength and a predefined shape to the elongate deflection member 560. For example, the support wires 581 can have a coil shape that extends longitudinally along the length of the elongate body 561. The coil shape allows for the longitudinal force applied near or at the first end 563 of the deflection member 560 to be transferred through the elongate body 561 so as to laterally extend the second end 565 of the deflection member 560 from the second opening 558 of the deflection lumen 554.
  • The support wires 581 can also provide the deflection member 560 with a predetermined shape upon laterally extending from the second opening 558 of the deflection lumen 554. The predetermined shape can be determined to engage the luminal wall of the pulmonary artery in order to bring the electrodes 514 on the second portion 572 of the offset region 564 into contact with the vascular tissue. The predetermined shape and the support wires 581 can also help to impart stiffness to the deflection member 560 that is sufficient to maintain the electrodes 514 on the luminal wall of the pulmonary artery under the conditions within the vasculature of the patient.
  • The support wires 581 can be formed of a variety of metals or metal alloys. Examples of such metals or metal alloys include surgical grade stainless steel, such as austenitic 316 stainless among others, and the nickel and titanium alloy known as Nitinol. Other metals and/or metal alloys, as are known, can be used.
  • Referring now to FIG. 6, there is shown an additional embodiment of a catheter 662 according to the present disclosure. The catheter 662 can include the features and components as discussed above for catheters 100, 200, 300, 400 and/or 500, a discussion of which is not repeated but the element numbers are included in FIG. 6 with the understanding that the discussion of these elements is implicit.
  • The catheter 662 seen in FIG. 6 is similar to the catheter 562 of FIG. 5, where the elongate body 602 of catheter 662 further includes three or more surfaces 612 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 608, as discussed for the catheters 100, 200, 300 and 400 herein. As illustrated, the one or more electrodes 614 are on one surface of the three or more surfaces 612 of the elongate body 602. In the present embodiment, the three or more surfaces 612 of the elongate body 602 help to form the second portion 672 of the elongate body 602. If desired, the elongate body 602 can includes a serpentine portion proximal to the one or more electrodes 614.
  • Referring now to FIG. 7, there is shown an additional embodiment of a catheter 782 according to the present disclosure. The catheter 782 can include the features and components as discussed above for catheters 100, 200, 300, 400, 500 and/or 600, a discussion of which is not repeated but the element numbers are included in FIG. 7 with the understanding that the discussion of these elements is implicit.
  • The catheter 782 includes an elongate body 702 having a peripheral surface 736 and a longitudinal center axis 708 extending between a first end 704 and a second end 706. The elongate body 702 includes a surface 752 defining a deflection lumen 754, where the deflection lumen 754 includes a first opening 756 and a second opening 758 in the elongate body 702. The catheter 782 further includes an inflatable balloon 734 on the peripheral surface 736 of the elongate body 702, the inflatable balloon 734 having a balloon wall 738 with an interior surface 740 that along with a portion 742 of the peripheral surface 736 of the elongate body 702 defines a fluid tight volume 744, as discussed herein. An inflation lumen 746 extends through the elongate body 702, where the inflation lumen 746 has a first opening 748 into the fluid tight volume 744 of the inflatable balloon 734 and a second opening 750 proximal to the first opening 748 to allow for a fluid to move in the fluid tight volume 744 to inflate and deflate the balloon 734.
  • One or more electrodes 714 are on the elongate body 702, where the second opening 758 of the deflection lumen 754 is opposite the one or more electrodes 714 on the elongate body 702. The catheter 782 further includes an elongate deflection member 760, as discussed herein, where the elongate deflection member 760 extends through the second opening 758 of the deflection lumen 754 in a direction opposite the one or more electrodes 714 on one surface of the elongate body 702. The catheter 782 also includes conductive elements 716, as discussed herein, that extend through the elongate body 702, where the conductive elements 716 conduct electrical current to combinations of the one or more electrodes 714.
  • The catheter 782 further includes a surface 724 defining a guide-wire lumen 726 that extends through the elongate body 702. As illustrated, the guide-wire lumen 726 is concentric relative the longitudinal center axis 708. As discussed herein, the guide-wire lumen 726 could also be eccentric relative longitudinal center axis 708 of the elongate body 708. Such embodiments are discussed herein, where the guide-wire lumen 726 can have a wall thickness taken perpendicularly to the longitudinal center axis 708 that is greater than a wall thickness of a remainder of the catheter 782 taken perpendicularly to the longitudinal center axis 708. The catheter 782 can also include a serpentine portion of the elongate body 702 proximal to the one or more electrodes 714, as discussed herein.
  • Referring now to FIG. 8, there is shown an additional embodiment of a catheter 882 according to the present disclosure. The catheter 882 can include the features and components as discussed above for catheters 100, 200, 300, 400, 500, 600 and/or 700, a discussion of which is not repeated but the element numbers are included in FIG. 8 with the understanding that the discussion of these elements is implicit.
  • The catheter 882 includes an elongate body 802 having a peripheral surface 836 and a longitudinal center axis 808 extending between a first end 804 and a second end 806. The elongate body 802 includes a surface 852 defining a deflection lumen 854, where the deflection lumen 854 includes a first opening 856 and a second opening 858 in the elongate body 802. The catheter 882 further includes an inflatable balloon 834 on the peripheral surface 836 of the elongate body 802, the inflatable balloon 834 having a balloon wall 838 with an interior surface 840 that along with a portion 842 of the peripheral surface 836 of the elongate body 802 defines a fluid tight volume 844, as discussed herein. An inflation lumen 846 extends through the elongate body 802, where the inflation lumen 846 has a first opening 848 into the fluid tight volume 844 of the inflatable balloon 834 and a second opening 850 proximal to the first opening 848 to allow for a fluid to move in the fluid tight volume 844 to inflate and deflate the balloon 834.
  • One or more electrodes 814 are on the elongate body 802, where the second opening 858 of the deflection lumen 854 is opposite the one or more electrodes 814 on the elongate body 802. As illustrated, the elongate body 802 has three or more surfaces 812 defining a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis 808. The one or more electrodes 814 are on one surface of the three or more surfaces 812 of the elongate body 802, as discussed herein.
  • The catheter 882 further includes an elongate deflection member 860, as discussed herein, where the elongate deflection member 860 extends through the second opening 858 of the deflection lumen 854 in a direction opposite the one or more electrodes 814 on one surface of the elongate body 802. The catheter 882 also includes conductive elements 816, as discussed herein, that extend through the elongate body 802, where the conductive elements 816 conduct electrical current to combinations of the one or more electrodes 814.
  • The catheter 882 further includes a surface 824 defining a guide-wire lumen 826 that extends through the elongate body 802. As illustrated, the guide-wire lumen 826 is concentric relative the longitudinal center axis 808. As discussed herein, the guide-wire lumen 826 could also be eccentric relative longitudinal center axis 808 of the elongate body 808. Such embodiments are discussed herein, where the guide-wire lumen 826 can have a wall thickness taken perpendicularly to the longitudinal center axis 808 that is greater than a wall thickness of a remainder of the catheter 882 taken perpendicularly to the longitudinal center axis 808. The catheter 882 can also include a serpentine portion of the elongate body 802 proximal to the one or more electrodes 814, as discussed herein.
  • Referring now to FIG. 9, there is shown an additional embodiment of a catheter 984 according to the present disclosure. The catheter 984 can include the features and components as discussed above for catheters 100, 200, 300, 400, 500, 600, 700 and/or 800, a discussion of which is not repeated but the element numbers are included in FIG. 9 with the understanding that the discussion of these elements is implicit.
  • The catheter 984 includes an elongate body 902 having a peripheral surface 936 and a longitudinal center axis 908 extending between a first end 904 and a second end 906. The catheter 984 further includes an inflatable balloon 934 on the peripheral surface 936 of the elongate body 902, the inflatable balloon 934 having a balloon wall 938 with an interior surface 940 that along with a portion 942 of the peripheral surface 936 of the elongate body 902 defines a fluid tight volume 944, as discussed herein. An inflation lumen 946 extends through the elongate body 902, where the inflation lumen 946 has a first opening 948 into the fluid tight volume 944 of the inflatable balloon 934 and a second opening 950 proximal to the first opening 948 to allow for a fluid to move in the fluid tight volume 944 to inflate and deflate the balloon 934.
  • The catheter 982 includes a surface 924 defining a guide-wire lumen 926 that extends through the elongate body 902. As illustrated, the guide-wire lumen 926 is concentric relative the longitudinal center axis 908. As discussed herein, the guide-wire Lumen 926 could also be eccentric relative longitudinal center axis 908 of the elongate body 908. Such embodiments are discussed herein, where the guide-wire lumen 926 can have a wall thickness taken perpendicularly to the longitudinal center axis 908 that is greater than a wall thickness of a remainder of the catheter 982 taken perpendicularly to the longitudinal center axis 908. The catheter 982 can also include a serpentine portion of the elongate body 902 proximal to the one or more electrodes 914, as discussed herein.
  • The elongate body 902 of the catheter 984 further includes a surface 986 defining an electrode lumen 988. The electrode lumen 988 includes a first opening 990 and a second opening 992 in the elongate body 902. The catheter 984 also includes an elongate electrode member 994, where the elongate electrode member 994 retractably extends through the first opening 990 of the electrode lumen 988 of the elongate body 902. The electrode lumen 988 has a size (e.g., a diameter) sufficient to allow the elongate electrode member 994 to pass through the electrode lumen 988 to that the elongate electrode member 994 can retractably extend through the first opening 990 of the electrode lumen 988 of the elongate body 902. The elongate electrode member 994 can retractably extend through the first opening 990 of the electrode lumen 988 of the elongate body 902 from pressure (e.g., compression or tension) applied by the user through the elongate electrode member 994 proximal to the second opening 992 in the elongate body 908. For the various embodiments, the elongate electrode member 994 is formed of a flexible polymeric material. Examples of such flexible polymeric material include, but are not limited to, those provided herein.
  • The elongate electrode member 994 includes one or more electrodes 996 and conductive elements 998 extending through the electrode lumen 988. As illustrated, the one or more electrodes 996 are on the surface 901 of the elongate electrode member 994. Conductive elements 998 extend through the elongate electrode member 994, where the conductive elements 998 can be used, as discussed herein, to conduct electrical current to combinations of the one or more electrodes 996. Each of the one or more electrodes 996 is coupled to a corresponding conductive element 998.
  • The conductive elements 998 are electrically isolated from each other and extend through the elongate electrode member 994 from each respective electrode 996 through the second end 992 of the electrode lumen 988. The conductive elements 998 terminate at a connector port, where each of the conductive elements 998 can be releasably coupled to a stimulation system, as discussed herein. It is also possible that the conductive elements 998 are permanently coupled to the stimulation system (e.g., not releasably coupled). The stimulation system can be used to conduct electrical current to combinations of the one or more electrodes 994 via the conductive elements 998. The one or more electrodes 996 are electrically isolated from one another, where the elongate electrode member 994 is formed of an electrically insulating material as discussed herein.
  • There can be a variety of the number and the configuration of the one or more electrodes 996 on the elongate electrode member 994. For example, as illustrated, the one or more electrodes 996 can be configured as an array of electrodes, where the number of electrodes and their relative position to each other can vary depending upon the desired implant location. As discussed herein, the one or more electrodes 996 can be configured to allow for electrical current to be delivered from and/or between different combinations of the one or more electrodes 996. So, for example, the electrodes in the array of electrodes can have a repeating pattern where the electrodes are equally spaced from each other. Other patterns are possible, where such patterns can either be repeating patterns or random patterns.
  • As illustrated, the one or more electrodes 996 have an exposed face 903. The exposed face 903 of the electrode 996 provides the opportunity for the electrode 996, when implanted in the patient, to be placed into proximity and/or in contact with the vascular tissue of the patient, as opposed to facing into the volume of blood in the artery. To accomplish this, the one or more electrodes 996 can be located on only one side of the elongate electrode member 994 (as illustrated in FIG. 9). This allows the one or more electrodes 996 to be brought into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries). As the one or more electrodes 996 are located on only one side of the elongate electrode member 994, the electrodes 996 can be placed into direct proximity to and/or in contact with, the tissue of any combination of the main pulmonary artery, the left pulmonary artery and/or the right pulmonary artery.
  • The exposed face 903 of the one or more electrodes 996 can have a variety of shapes, as discussed herein (e.g., a partial ring configuration, where each of the one or more electrodes 996 is positioned to face away from the elongate body 902). The exposed face 903 of the electrodes 996 can also include one or more anchor structures. Examples of such anchor structures include hooks that can optionally include a barb.
  • As generally illustrated, the elongate electrode member 994 can be advanced through the electrode lumen 988 so that the elongate electrode member 994 extends laterally away from the elongate body 908. The elongate electrode member 994 can be of a length and shape that allows the elongate electrode member 994 to be extended a distance sufficient from the elongate body 908 to bring the one or more electrodes 996 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries).
  • As illustrated in FIG. 9, the elongate electrode member 994 forms a loop 905 that extends away from the peripheral surface 936 of the elongate body 902. The loop 905 can have a variety of configurations relative the longitudinal axis 908 of the elongate body 902. For example, as illustrated in FIG. 9, the elongate electrode member 992 forming the loop 905 is in a plane 907 that is co-linear with the longitudinal center axis 908 of the elongate body 902.
  • The catheter 984 further includes an elongate deflection member 960, as previously discussed. As discussed herein, pressure is applied to the deflection member 960 to move the first end 963 of the deflection member 960 towards the first opening 956 of the deflection lumen 954. The pressure in addition to moving the first end 963 of the deflection member 960 towards the first opening 956 also causes the second end 965 of the deflection member 960 to extend from the second opening 958. As generally illustrated, the elongate deflection member 960 can be advanced through the deflection lumen 954 so that elongate deflection member 960 extends laterally away from the one or more electrodes 996 on the elongate electrode member 994. The elongate deflection member 960 can be of a length and shape that allows the elongate deflection member 960 to be extended a distance sufficient to help bring the one or more electrodes 996 into contact with the vascular luminal surface (e.g., a posterior surface of the main pulmonary artery and/or one or both of the pulmonary arteries) with a variety of pressures. Optionally, the elongate deflection member 960 can be configured to include one or more of the electrode, as discussed herein.
  • The catheter 984 shown in FIG. 9 can be positioned in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. To accomplish this, a pulmonary artery guide catheter is introduced into the vasculature through a percutaneous incision and guided to the right ventricle using known techniques. For example, the pulmonary artery guide catheter can be inserted into the vasculature via a peripheral vein of the arm (e.g., as with a peripherally inserted central catheter). Changes in a patient's electrocardiography and/or pressure signals from the vasculature can be used to guide and locate the pulmonary artery guide catheter within the patient's heart. Once in the proper location, a guide wire can be introduced into the patient via the pulmonary artery guide catheter, where the guide wire is advanced into the main pulmonary artery and/or one of the pulmonary arteries. Using the guide-wire lumen 926, the catheter 984 can be advanced over the guide wire so as to position the catheter 984 in the main pulmonary artery and/or one or both of the pulmonary arteries of the patient, as described herein. Various imaging modalities can be used in positioning the guide wire of the present disclosure in the main pulmonary artery and/or one of the pulmonary arteries of the patient. Such imaging modalities include, but are not limited to, fluoroscopy, ultrasound, electromagnetic, electropotential modalities.
  • Using a stimulation system, as discussed herein, stimulation electrical energy can be delivered across combinations of one or more of the electrodes 996. It is possible for the patient's cardiac response to the stimulation electrical energy to be monitored and recorded for comparison to other subsequent tests. It is appreciated that for any of the catheters discussed herein any combination of electrodes, including reference electrodes (as discussed herein) positioned within or on the patient's body, can be used in providing stimulation to and sensing cardiac signals from the patient.
  • Referring now to FIG. 10, there is shown an additional embodiment of a catheter 1084 according to the present disclosure. The catheter 1084 can include the features and components as discussed above for catheters 100, 200, 300, 400, 500, 600, 700, 800 and/or 900, a discussion of which is not repeated but the element numbers are included in FIG. 10 with the understanding that the discussion of these elements is implicit. The catheter 1084 illustrates an embodiment in which the elongate electrode member 1094 forms the 1005 loop in a plane 1007 that is perpendicular to the longitudinal center axis of the elongate body.
  • It is appreciated that more than one of the elongate electrode member can be used with a catheter.
  • For the various embodiments, the electrode can have a variety of configurations and sizes. For example, the electrodes discussed herein can be ring-electrodes that fully encircle the body on which they are located. The electrodes discussed herein can also be a partial ring, where the electrode only partially encircles the body on which they are located. For example, the electrodes can be partial ring electrodes that preferably only contact the luminal surface of the main pulmonary artery and/or pulmonary arteries, as discussed herein. This configuration may help to localize the stimulation electrical energy, as discussed herein, into the vascular and adjacent tissue structures (e.g., autonomic fibers) and away from the blood. The electrodes and conductive elements provided herein can be formed of a conductive biocompatible metal or metal alloy. Examples of such conductive biocompatible metal or metal alloys include, but are not limited to, titanium, platinum or alloys thereof. Other biocompatible metal or metal alloys are known.
  • For the various embodiments, the elongate body of the catheters provided herein can be formed of a flexible polymeric material. Examples of such flexible polymeric material include, but are not limited to, medical grade polyurethanes, such as polyester-based polyurethanes, polyether-based polyurethanes, and polycarbonate-based polyurethanes; polyamides, polyamide block copolymers, polyolefins such as polyethylene (e.g., high density polyethylene); and polyimides, among others.
  • Each of the catheters discussed herein can further include one or more reference electrodes positioned proximal to the one or more electrodes present on the elongate body. These one or more reference electrodes each include insulated conductive leads that extend from the catheter so as to allow the one or more reference electrodes to be used as common or return electrodes for electrical current that is delivered through one or more of the one or more electrodes on the elongate body of the catheter.
  • The catheters of the present disclosure can be used to treat a patient with various cardiac conditions. Such cardiac conditions include, but are not limited to, acute heart failure, among others. As discussed herein, the one or more electrodes present on the catheter can be positioned within the main pulmonary artery and/or one or both of the pulmonary arteries. Preferably, the one or more electrodes are positioned in contact the luminal surface of the main pulmonary artery (e.g., in physical contact with the surface of the posterior portion of the main pulmonary artery). As will be discussed herein, the one or more electrodes on the catheter provided herein can be used to provide pulse of electrical energy between the electrodes and/or the reference electrodes. The electrodes of the present disclosure can be used in any one of a unipolar, bi-polar and/or a multi-polar configuration. Once positioned, the catheter of the present disclosure can provide the stimulation electrical energy to stimulate the nerve fibers (e.g., autonomic nerve fibers) surrounding the main pulmonary artery and/or one or both of the pulmonary arteries in an effort to provide adjuvant cardiac therapy to the patient (e.g., electrical cardiac neuromodulation).
  • In addition to the catheters of the present disclosure, one or more sensing electrodes can be located on or within the patent. Among other things, the sensing electrodes can be used to detect signals indicting changes in various cardiac parameters, where these changes can be the result of the pulse of stimulation electrical energy delivered to stimulate the nerve fibers (e.g., autonomic nerve fibers) surrounding the main pulmonary artery and/or one or both of the pulmonary arteries. Such parameters include, but are not limited to, the patient's heart rate (e.g., pulse), among other parameters. The sensing electrodes can also provide signals indicting changes in one or more electrical parameter of vasculature (electrical activity of the cardiac cycle). Such signals can be collected and displayed, as are known, using known devices (e.g., electrocardiography (ECG) monitor) or a stimulation system, as discussed herein, which receives the detected signals and provides information about the patient.
  • Other sensors can also be used with the patient to detect and measure a variety of other signals indicting changes in various cardiac parameters. Such parameters can include, but are not limited to, blood pressure, blood oxygen level and/or gas composition of the patient's exhaled breath. For example, catheter of the present disclosure can further include a pressure sensor positioned within or in-line with the inflation lumen for the inflatable balloon. Signals from the pressure sensor can be used to both detect and measure the blood pressure of the patient. Alternatively, the catheter of the present disclosure can include an integrated circuit for sensing and measuring blood pressure and/or a blood oxygen level. Such an integrated circuit can be implemented using 0.18 μm CMOS technology. The oxygen sensor can be measured with optical or electrochemical techniques as are known. Examples of such oxygen sensors include reflectance or transmissive pulse oximetry those that use changes in absorbance in measured wavelengths optical sensor to help determined a blood oxygen level. For these various embodiments, the elongate body of the catheter can include the sensor (e.g., a blood oxygen sensor and/or a pressure sensor) and a conductive element, or elements, extending through each of the elongate body, where the conductive element conducts electrical signals from the blood oxygen sensor and/or the pressure sensor.
  • The detected signals can also be used by the stimulation system to provide stimulation electrical energy in response to the detected signals. For example, one or more of these signals can be used by the stimulation system to deliver the stimulation electrical energy to the one or more electrodes of the catheter. So, for example, detected signals from the patent's cardiac cycle (e.g., ECG waves, wave segments, wave intervals or complexes of the ECG waves) can be sensed using the sensing electrodes and/or timing parameter of the subject's blood pressure. The stimulation system can receive these detected signals and based on the features of the signal(s) generate and deliver the stimulation electrical energy to the one or more electrode of the catheter. As discussed herein, the stimulation electrical energy is of sufficient current and potential along with a sufficient duration to stimulate one or more of the nerve fibers surrounding the main pulmonary artery and/or one or both of the pulmonary arteries so as to provide neuromodulation to the patient.
  • Referring now to FIG. 11, there is shown an illustration of a main pulmonary artery 11500 of a heart 11502. The main pulmonary artery 11500 begins at the base of the right ventricle 11504, having a diameter of approximately 3 centimeter (1.2 in) and a length of about approximately 5 centimeters (2.0 in). The main pulmonary artery 11500 branches into two pulmonary arteries (left and right) 11501, which deliver deoxygenated blood to the corresponding lung. As illustrated, the main pulmonary artery 11500 has a posterior surface 11506 that arches over the left atrium and is adjacent the pulmonary vein. As discussed herein, the one or more electrodes of the catheter of the present disclosure are positioned at least partially within the main pulmonary artery and/or a pulmonary artery with the electrode in contact with the posterior surface 11506. One preferred location for positioning the one or more electrodes of the catheter of the present disclosure is the right pulmonary artery as disclosed in U.S. Provisional Patent Application 62/______ entitled “METHODS FOR ELECTRICAL NEUROMODULATION OF THE HEART” filed on Sep. 8, 2014, which is incorporated herein by reference in its entirety. Other locations along the lumen of the main pulmonary artery and/or pulmonary arteries are also possible.
  • Preferably, the one or more electrodes of the catheter of the present disclosure are in contact with the posterior surface 11506 of the main pulmonary artery 11500 and/or pulmonary arteries 11501. From this location, the stimulation electrical energy delivered through the one or more electrodes may be better able to treat and/or provide therapy (including adjuvant therapy) to the patient experiencing a variety of cardiovascular medical conditions, such as acute heart failure. The stimulation electrical energy can elicit responses from the autonomic nervous system that may help to modulate a patient's cardiac contractility. The stimulation electrical energy is intended to affect heart contractility more than the heart rate, thereby helping to improving hemodynamic control while possibly minimizing unwanted systemic effects.
  • As discussed herein, the catheter of the present disclosure can be positioned in the pulmonary artery of the patient, where the one or more electrodes are positioned in contact the luminal surface of the main pulmonary artery (e.g., in physical contact with the surface of the posterior portion of the main pulmonary artery). The stimulation system is electrically coupled to the one or more electrodes via the conductive elements, where the stimulation system can be used to deliver the stimulation electrical energy to the autonomic cardiopulmonary fibers surrounding the main pulmonary artery.
  • The stimulation system is used to operate and supply the stimulation electrical energy to the one or more electrodes of the catheter. The stimulation system controls the various parameters of the stimulation electrical energy delivered across the one or more electrodes. Such parameters include control of each electrodes polarity (e.g., used as a cathode or an anode), pulsing mode (e.g., unipolar, bi-polar and/or multi-polar), a pulse width, an amplitude, a frequency, a voltage, a current, a duration, a wavelength and/or a waveform associated with the stimulation electrical energy. The stimulation system may operate and supply the stimulation electrical energy to different combinations and numbers of the one or more electrodes, including the reference electrodes discussed herein. The stimulation system can be external to the patient's body for use by the professional to program the stimulation system and to monitor its performance. Alternatively, the stimulation system could be internal to the patient's body. When located within the patient, the housing of the stimulation system can be used as a reference electrode for both sensing and unipolar pulsing mode.
  • As discussed herein, the stimulation system can be used to help identify a preferred location for the position of the one or more electrodes along the luminal surface of the main pulmonary artery. To this end, the one or more electrodes of the catheter are introduced into the patient and tests of various locations along the luminal surface of the main pulmonary artery using the stimulation system are conducted so as to identify a preferred location for the electrodes, as discussed herein. During such a test, the stimulation system can be used to initiate and adjust the parameters of the stimulation electrical energy. Such parameters include, but are not limited to, terminating, increasing, decreasing, or changing the rate or pattern of the stimulation electrical energy. The stimulation system can also deliver stimulation electrical energy that are episodic, continuous, phasic, in clusters, intermittent, upon demand by the patient or medical personnel, or preprogrammed to respond to a signal, or portion of a signal, sensed from the patient.
  • By way of example, the stimulation electrical energy can have a voltage of about 0.1 microvolts to about 75 volts (V), where voltage values of 1 V to 50 V, or 0.1 V to 10 V are also possible. The stimulation electrical energy can be delivered at a frequency of about 1 Hertz (Hz) to about 100,000 Hz, where frequency values of about 2 Hz to about 200 Hz are also possible. The stimulation electrical energy can have a pulse width of about 100 microseconds to about 100 milliseconds. The stimulation electrical energy can also have a variety of wave forms, such as for example, square wave, biphasic square wave, sine wave, or other electrically safe and feasible combinations. The stimulation electrical energy may be applied to multiple target sites simultaneously or sequentially.
  • An open-loop or closed-loop feedback mechanism may be used in conjunction with the present disclosure. For the open-loop feedback mechanism, a professional can monitor cardiac parameters and changes to the cardiac parameters of the patient. Based on the cardiac parameters the professional can adjust the parameters of the stimulation electrical energy applied to autonomic cardiopulmonary fibers. Non-limiting examples of cardiac parameters monitored include arterial blood pressure, central venous pressure, capillary pressure, systolic pressure variation, arterial blood gases, cardiac output, systemic vascular resistance, pulmonary artery wedge pressure, gas composition of the patient's exhaled breath and/or mixed venous oxygen saturation. Cardiac parameters can be monitored by an electrocardiogram, invasive hemodynamics, an echocardiogram, or blood pressure measurement or other devices known in the art to measure cardiac function. Other parameters such as body temperature and respiratory rate can also be monitored and processed as part of the feedback mechanism.
  • In a closed-loop feedback mechanism, the cardiac parameters of the patient are received and processed by the stimulation system, as discussed herein, where the parameters of the stimulation electrical energy are adjusted based at least in part on the cardiac parameters. As discussed herein, a sensor is used to detect a cardiac parameter and generate a sensor signal. The sensor signal is processed by a sensor signal processor, which provides a control signal to a signal generator. The signal generator, in turn, can generate a response to the control signal by activating or adjusting one or more of the parameters of the stimulation electrical energy applied by the catheter to the patient. The control signal can initiate, terminate, increase, decrease or change the parameters of the stimulation electrical energy. It is possible for the one or more electrodes of the catheter to be used as a sensor a recording electrode. When necessary these sensing or recording electrodes may delivery stimulation therapy as discussed herein.
  • The stimulation system can also monitor to determine if the one or more electrodes have dislodged from their position within the main pulmonary artery and/or one or both of the pulmonary arteries (the right pulmonary artery and the left pulmonary artery). For example, the stimulation system can monitor the voltage levels of the stimulation electrical energy delivered and received by the one or more electrodes once the catheter is implanted. If the voltage levels received by the one or more electrode change by a predetermined percentage, a warning signal is produced by the stimulation system and the stimulation electrical energy is stopped.
  • Referring now to FIG. 12, there is shown an embodiment of the stimulation system 12600. The stimulation system 12600 includes an input/output connector 12602 that releasably joins the conductive elements of the catheter of the present disclosure. It is also possible that the conductive elements are permanently coupled to the stimulation system (e.g., not releasably coupled). An input from the sensor can also be releasably coupled to the input/output connector 12602 so as to receive the sensor signal(s) discussed herein.
  • The input/output connector 12602 is connected to an analog to digital converter 12604. The output of the analog to digital converter 12604 is connected to a microprocessor 12606 through a peripheral bus 12608 including address, data and control lines. Microprocessor 12606 can process the sensor data, when present, in different ways depending on the type of sensor in use. The microprocessor 12606 can also control, as discussed herein, the pulse control output generator 12610 that delivers the stimulation electrical energy to the one or more electrodes via the input/output connector 12602.
  • The parameters of the stimulation electrical energy can be controlled and adjusted, as needed, by instructions programmed in a memory 12612 and executed by a programmable pulse generator 12613. The instructions in memory 12612 for the programmable pulse generator 12613 can be set and/or modified based on input from the closed-looped system, via the microprocessor 12606. The instructions in memory 12612 for the programmable pulse generator 12613 can also be set and/or modified through inputs from a professional via an input 12614 connected through the peripheral bus 12608. Examples of such an input include a keyboard with a display screen or through a touch screen (not shown), as are known. The stimulation system 12600 can also include a communications port 12615 that connects to the peripheral bus 12608, where data and/or programming instructions can be received by the microprocessor 12606 and/or the memory 12612.
  • Input from either a professional via the input 12614, the communications port 12615 or from the closed-looped system via the microprocessor 12606 can be used to change (e.g., adjust) the parameters of the stimulation electrical energy. The stimulation system 12600 can also include a power source 12616. The power source 12616 can be a battery or a power source supplied from an external power supply (e.g., an AC/DC power converter coupled to an AC source). The programmable pulse generator 12612 can also include a housing 12618.
  • The microprocessor 12606 can execute one or more algorithms in order to provide stimulation with closed loop feedback control. The microprocessor 12606 can also be controlled by a professional via the input 12614 to initiate, terminate and/or change (e.g., adjust) the parameters of the stimulation electrical energy. The closed loop feedback control can be used to help maintain one or more of a patient's cardiac parameters at or within a threshold value or range programmed into memory 12612. For example, under closed loop feedback control measured cardiac parameter value(s) can be compared and then it can be determine whether or not the measured value(s) lies outside a threshold value or a pre-determined range of values. If the measured cardiac parameter value(s) do not fall outside of the threshold value or the pre-determined range of values, the closed loop feedback control continues to monitor the cardiac parameter value(s) and repeats the comparison on a regular interval. If, however, the cardiac parameter value(s) from a sensor indicate that one or more cardiac parameters are outside of the threshold value or the pre-determined range of values one or more of the parameters of the stimulation electrical energy will be adjusted by the microprocessor 12606. The adjustments can be made using process control logic (e.g., fuzzy logic, negative feedback, etc.) so as to maintain control of the pulse control output generator 12610.
  • Although preferred illustrative variations of the present disclosure are described above, it will be apparent to those skilled in the art that various changes and modifications may be made thereto without departing from the embodiments of the present disclosure. It is intended in the appended claims to cover all such changes and modifications that fall within the true spirit and scope of the disclosure.

Claims (21)

1. (canceled)
2. A catheter for use in electrical neuromodulation, the catheter comprising:
an elongate body having a proximal portion and a distal portion, the distal portion comprising:
a balloon expandable to be carried by a flow of blood to a pulmonary artery; and
an electrode array configured to extend from the elongate body, the electrode array comprising a plurality of electrodes in a column and row configuration and electrically isolated from each other, the electrode array configured to apply bipolar neuromodulation energy to the right pulmonary artery to increase cardiac contractility to treat acute heart failure,
wherein the elongate body comprises:
an inflation lumen extending from the proximal portion to the balloon; and
a conductor lumen containing a plurality of conductors extending from the proximal portion to the electrode array, each one of the conductors of the plurality of conductors coupled to one electrode of the plurality of electrodes,
the proximal portion comprising a connector port coupled to the plurality of conductors, the connector port configured to be coupled to a stimulation system.
3. The catheter of claim 2, further comprising a pressure sensor.
4. The catheter of claim 3, wherein the elongate body comprises the pressure sensor.
5. The catheter of claim 2, wherein the elongate body comprises a marker configured to make the elongate body visible under an imaging modality.
6. The catheter of claim 2, wherein the elongate body comprises a pressure sensor, and wherein the elongate body comprises a marker configured to make the elongate body visible under an imaging modality.
7. A catheter for use in electrical neuromodulation, the catheter comprising:
an elongate body having a proximal portion and a distal portion, the distal portion comprising:
a balloon expandable to be carried by a flow of blood to a pulmonary artery; and
an electrode array comprising a plurality of electrodes electrically isolated from each other, the electrode array configured to apply neuromodulation energy to the pulmonary artery to increase cardiac contractility,
wherein the elongate body comprises:
an inflation lumen extending from the proximal portion to the balloon; and
a conductor lumen containing a plurality of conductors extending from the proximal portion to the electrode array, each one of the conductors of the plurality of conductors coupled to one electrode of the plurality of electrodes.
8. The catheter of claim 7, wherein the proximal portion comprises a connector port coupled to the plurality of conductors, the connector port configured to be coupled to a stimulation system.
9. The catheter of claim 7, wherein the balloon is configured to be carried by the flow of blood to the right pulmonary artery.
10. The catheter of claim 7, wherein the elongate body comprises a pressure sensor.
11. The catheter of claim 7, wherein the electrode array comprises a column and row configuration, wherein the electrode array is configured to extend from the elongate body, and wherein the elongate body comprises a pressure sensor.
12. A catheter for use in electrical neuromodulation, the catheter comprising:
an elongate body having a proximal portion and a distal portion, the distal portion comprising:
a balloon expandable to be carried by a flow of blood to a pulmonary artery; and
an electrode array comprising a plurality of electrodes electrically isolated from each other, the electrode array configured to apply energy to the pulmonary artery,
wherein the elongate body comprises:
an inflation lumen extending from the proximal portion to the balloon; and
a conductor lumen containing a plurality of conductors extending from the proximal portion to the electrode array, each one of the conductors of the plurality of conductors coupled to one electrode of the plurality of electrodes.
13. The catheter of claim 12, wherein the proximal portion comprises a connector port coupled to the plurality of conductors, the connector port configured to be coupled to a stimulation system.
14. The catheter of claim 12, wherein the balloon is configured to be carried by the flow of blood to the right pulmonary artery.
15. The catheter of claim 12, wherein the electrode array comprises a column and row configuration.
16. The catheter of claim 12, wherein the electrode array is configured to extend from the elongate body.
17. The catheter of claim 12, wherein the electrode array is configured to be used in at least one of a unipolar, a bipolar, or a multipolar configuration.
18. The catheter of claim 12, wherein the electrode array is on an outer surface of the elongate body.
19. The catheter of claim 12, wherein the elongate body comprises a pressure sensor.
20. The catheter of claim 12, wherein the elongate body comprises a predefined curve between the proximal portion and the distal portion.
21. The catheter of claim 12, wherein the electrode array comprises a column and row configuration, wherein the electrode array is configured to extend from the elongate body, and wherein the elongate body comprises a pressure sensor.
US17/148,961 2014-09-08 2021-01-14 Floatable catheters for neuromodulation Abandoned US20210370068A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/148,961 US20210370068A1 (en) 2014-09-08 2021-01-14 Floatable catheters for neuromodulation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462047270P 2014-09-08 2014-09-08
PCT/US2015/047770 WO2016040037A1 (en) 2014-09-08 2015-08-31 Catheter and electrode systems for electrical neuromodulation
US15/446,872 US10894160B2 (en) 2014-09-08 2017-03-01 Catheter and electrode systems for electrical neuromodulation
US17/148,961 US20210370068A1 (en) 2014-09-08 2021-01-14 Floatable catheters for neuromodulation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/446,872 Continuation US10894160B2 (en) 2014-09-08 2017-03-01 Catheter and electrode systems for electrical neuromodulation

Publications (1)

Publication Number Publication Date
US20210370068A1 true US20210370068A1 (en) 2021-12-02

Family

ID=54140673

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/446,872 Active 2036-10-31 US10894160B2 (en) 2014-09-08 2017-03-01 Catheter and electrode systems for electrical neuromodulation
US17/148,961 Abandoned US20210370068A1 (en) 2014-09-08 2021-01-14 Floatable catheters for neuromodulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/446,872 Active 2036-10-31 US10894160B2 (en) 2014-09-08 2017-03-01 Catheter and electrode systems for electrical neuromodulation

Country Status (5)

Country Link
US (2) US10894160B2 (en)
EP (1) EP3194007B1 (en)
AU (1) AU2015315658B2 (en)
CA (1) CA2957791A1 (en)
WO (1) WO2016040037A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11559687B2 (en) 2017-09-13 2023-01-24 CARDIONOMIC, Inc. Methods for detecting catheter movement
US11607176B2 (en) 2019-05-06 2023-03-21 CARDIONOMIC, Inc. Systems and methods for denoising physiological signals during electrical neuromodulation
US11648395B2 (en) 2018-08-13 2023-05-16 CARDIONOMIC, Inc. Electrode assemblies for neuromodulation
US11806159B2 (en) 2016-03-09 2023-11-07 CARDIONOMIC, Inc. Differential on and off durations for neurostimulation devices and methods

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008070189A2 (en) 2006-12-06 2008-06-12 The Cleveland Clinic Foundation Method and system for treating acute heart failure by neuromodulation
SG10201808553QA (en) 2014-05-22 2018-11-29 Cardionomic Inc Catheter and catheter system for electrical neuromodulation
AU2015315570B2 (en) 2014-09-08 2020-05-14 CARDIONOMIC, Inc. Methods for electrical neuromodulation of the heart
JP6099611B2 (en) * 2014-10-22 2017-03-22 日出夫 文山 Medical pressure gauge
US10493278B2 (en) 2015-01-05 2019-12-03 CARDIONOMIC, Inc. Cardiac modulation facilitation methods and systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6532388B1 (en) * 1996-04-30 2003-03-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US8204606B2 (en) * 2002-12-19 2012-06-19 Cardiac Pacemakers, Inc. Implantable lead for septal placement of pacing electrodes
US20120330092A1 (en) * 2011-06-23 2012-12-27 Akira Shiose Device, system, and method for modulating cardiac function
US20130072995A1 (en) * 2011-07-11 2013-03-21 Terrance Ransbury Catheter system for acute neuromodulation

Family Cites Families (332)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5067957A (en) 1983-10-14 1991-11-26 Raychem Corporation Method of inserting medical devices incorporating SIM alloy elements
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US4718423A (en) 1986-10-17 1988-01-12 Spectramed, Inc. Multiple-function cardiovascular catheter system with very high lumenal efficiency and no crossovers
US5365926A (en) 1986-11-14 1994-11-22 Desai Jawahar M Catheter for mapping and ablation and method therefor
US4947866A (en) 1988-02-16 1990-08-14 Medtronic, Inc. Medical electrical lead
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US5059177A (en) * 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
US5224491A (en) 1991-01-07 1993-07-06 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5156154A (en) 1991-03-08 1992-10-20 Telectronics Pacing Systems, Inc. Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniques
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5213098A (en) 1991-07-26 1993-05-25 Medtronic, Inc. Post-extrasystolic potentiation stimulation with physiologic sensor feedback
US5259387A (en) 1991-09-09 1993-11-09 Quinton Instrument Company ECG muscle artifact filter system
EP0633798B1 (en) 1992-03-31 2003-05-07 Boston Scientific Corporation Vascular filter
US5782239A (en) * 1992-06-30 1998-07-21 Cordis Webster, Inc. Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US5336244A (en) 1992-10-07 1994-08-09 Medtronic, Inc. Temperature sensor based capture detection for a pacer
IL116699A (en) 1996-01-08 2001-09-13 Biosense Ltd Method of constructing cardiac map
US5431649A (en) 1993-08-27 1995-07-11 Medtronic, Inc. Method and apparatus for R-F ablation
WO1995010978A1 (en) 1993-10-19 1995-04-27 Ep Technologies, Inc. Segmented electrode assemblies for ablation of tissue
JPH07178176A (en) 1993-12-24 1995-07-18 Terumo Corp Catheter
US5968040A (en) 1994-03-04 1999-10-19 Ep Technologies, Inc. Systems and methods using asymmetric multiple electrode arrays
US5423881A (en) 1994-03-14 1995-06-13 Medtronic, Inc. Medical electrical lead
US5598848A (en) 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5564434A (en) 1995-02-27 1996-10-15 Medtronic, Inc. Implantable capacitive absolute pressure and temperature sensor
US6059810A (en) 1995-05-10 2000-05-09 Scimed Life Systems, Inc. Endovascular stent and method
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
KR19990077062A (en) 1996-01-08 1999-10-25 니심 다비쉬 Cardiac Control Methods and Systems
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
IL125424A0 (en) 1998-07-20 1999-03-12 New Technologies Sa Ysy Ltd Pacing with hemodynamic enhancement
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
IL119261A0 (en) 1996-09-17 1996-12-05 New Technologies Sa Ysy Ltd Electrical muscle controller
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ.ヴイ. Electric muscle control device
US6363279B1 (en) 1996-01-08 2002-03-26 Impulse Dynamics N.V. Electrical muscle controller
US6415178B1 (en) 1996-09-16 2002-07-02 Impulse Dynamics N.V. Fencing of cardiac muscles
US5853411A (en) 1996-01-19 1998-12-29 Ep Technologies, Inc. Enhanced electrical connections for electrode structures
WO1997037720A1 (en) 1996-04-04 1997-10-16 Medtronic, Inc. Living tissue stimulation and recording techniques
FR2796562B1 (en) 1996-04-04 2005-06-24 Medtronic Inc TECHNIQUES FOR STIMULATING LIVING TISSUE AND RECORDING WITH LOCAL CONTROL OF ACTIVE SITES
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US5711316A (en) 1996-04-30 1998-01-27 Medtronic, Inc. Method of treating movement disorders by brain infusion
US6463324B1 (en) 1996-09-16 2002-10-08 Impulse Dynamics N. V. Cardiac output enhanced pacemaker
US6298268B1 (en) 1996-09-16 2001-10-02 Impulse Dynamics N.V. Cardiac output controller
EP1011795B1 (en) 1996-09-16 2010-03-10 Impulse Dynamics N.V. Cardiac output controller
US5755766A (en) 1997-01-24 1998-05-26 Cardiac Pacemakers, Inc. Open-ended intravenous cardiac lead
US5954761A (en) 1997-03-25 1999-09-21 Intermedics Inc. Implantable endocardial lead assembly having a stent
US5948007A (en) 1997-04-30 1999-09-07 Medtronic, Inc. Dual channel implantation neurostimulation techniques
US6547788B1 (en) 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
JP4102545B2 (en) 1997-07-16 2008-06-18 メタキュアー エヌブイ Smooth muscle control device
US6071308A (en) 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
US6231516B1 (en) 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US6058331A (en) 1998-04-27 2000-05-02 Medtronic, Inc. Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control
US6319241B1 (en) 1998-04-30 2001-11-20 Medtronic, Inc. Techniques for positioning therapy delivery elements within a spinal cord or a brain
US6447478B1 (en) 1998-05-15 2002-09-10 Ronald S. Maynard Thin-film shape memory alloy actuators and processing methods
US6428537B1 (en) 1998-05-22 2002-08-06 Scimed Life Systems, Inc. Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive
US6740113B2 (en) 1998-05-29 2004-05-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
WO1999065561A1 (en) 1998-06-19 1999-12-23 Cordis Webster, Inc. Method and apparatus for transvascular treatment of tachycardia and fibrillation
US6036697A (en) 1998-07-09 2000-03-14 Scimed Life Systems, Inc. Balloon catheter with balloon inflation at distal end of balloon
US6950689B1 (en) 1998-08-03 2005-09-27 Boston Scientific Scimed, Inc. Dynamically alterable three-dimensional graphical model of a body region
US5997563A (en) 1998-09-28 1999-12-07 Medtronic, Inc. Implantable stent having variable diameter
IL126905A0 (en) 1998-11-05 1999-09-22 Impulse Dynamics Ltd Multi-electrode catheter
US6675043B1 (en) 1998-11-06 2004-01-06 Impulse Dynamics N.V. Sensor-based regulation of excitable tissue control of the heart
US6292693B1 (en) 1998-11-06 2001-09-18 Impulse Dynamics N.V. Contractility enhancement using excitable tissue control and multi-site pacing
US6725093B1 (en) 1998-11-06 2004-04-20 Impulse Dynamics N.V. Regulation of excitable tissue control of the heart based on physiological input
WO2000027472A1 (en) 1998-11-06 2000-05-18 Impulse Dynamics Nv Trigger-based regulation of excitable tissue control in the heart
US6254610B1 (en) 1999-05-24 2001-07-03 Impulse Dynamics N.V. Device and method for dragging and positioning a member within a duct in a body
US6152882A (en) 1999-01-26 2000-11-28 Impulse Dynamics N.V. Apparatus and method for chronic measurement of monophasic action potentials
US6161029A (en) 1999-03-08 2000-12-12 Medtronic, Inc. Apparatus and method for fixing electrodes in a blood vessel
US6136021A (en) 1999-03-23 2000-10-24 Cardiac Pacemakers, Inc. Expandable electrode for coronary venous leads
US6370430B1 (en) 1999-03-25 2002-04-09 Impulse Dynamics N.V. Apparatus and method for controlling the delivery of non-excitatory cardiac contractility modulating signals to a heart
US6263242B1 (en) 1999-03-25 2001-07-17 Impulse Dynamics N.V. Apparatus and method for timing the delivery of non-excitatory ETC signals to a heart
US6522904B1 (en) 1999-03-30 2003-02-18 Impulse Dynamics N.V. Bipolar sensor for muscle tissue action potential duration estimation
EP1164929B1 (en) 1999-04-05 2007-01-03 The Regents Of The University Of California Endomyocardial monophasic action potential for early detection of myocardium pathology
US6353762B1 (en) 1999-04-30 2002-03-05 Medtronic, Inc. Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US6292704B1 (en) 1999-05-25 2001-09-18 Impulse Dynamics N. V. High capacitance myocardial electrodes
US6304777B1 (en) 1999-05-26 2001-10-16 Impulse Dynamics N.V. Induction of cardioplegia applied electrical signals
US6285906B1 (en) 1999-05-26 2001-09-04 Impulse Dynamics N. V. Muscle contraction assist device
US6442424B1 (en) 1999-05-26 2002-08-27 Impulse Dynamics N.V. Local cardiac motion control using applied electrical signals
AU4776000A (en) 1999-05-26 2000-12-18 Impulse Dynamic Nv Shockless defibrillation
US7092753B2 (en) 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
US7190997B1 (en) 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7171263B2 (en) 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US6233487B1 (en) 1999-06-08 2001-05-15 Impulse Dynamics N.V. Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions
US6223072B1 (en) 1999-06-08 2001-04-24 Impulse Dynamics N.V. Apparatus and method for collecting data useful for determining the parameters of an alert window for timing delivery of ETC signals to a heart under varying cardiac conditions
WO2001000273A1 (en) 1999-06-25 2001-01-04 Emory University Devices and methods for vagus nerve stimulation
US6348045B1 (en) 1999-07-12 2002-02-19 Impulse Dynamics N.V. Catheter with distal-end engaging means
US6335538B1 (en) 1999-07-23 2002-01-01 Impulse Dynamics N.V. Electro-optically driven solid state relay system
CA2314517A1 (en) 1999-07-26 2001-01-26 Gust H. Bardy System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system
US7303526B2 (en) 1999-08-09 2007-12-04 Cardiokinetix, Inc. Device for improving cardiac function
US6360126B1 (en) 1999-08-20 2002-03-19 Impulse Dynamics N.V. Apparatus and method for controlling the delivery of contractility modulating non-excitatory signals to the heart
US6360123B1 (en) 1999-08-24 2002-03-19 Impulse Dynamics N.V. Apparatus and method for determining a mechanical property of an organ or body cavity by impedance determination
US7027863B1 (en) 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
US6993385B1 (en) 1999-10-25 2006-01-31 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
AU1049901A (en) 1999-10-25 2001-05-08 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
US6295475B1 (en) 1999-10-27 2001-09-25 Pacesetter, Inc. Single-pass atrial ventricular lead with multiple atrial ring electrodes and a selective atrial electrode adaptor for the coronary sinus region
US6662055B1 (en) 1999-12-17 2003-12-09 Impulse Dynamics Nv Multi-electrode intravascular lead
IL133592A0 (en) 1999-12-19 2001-04-30 Impulse Dynamics Ltd Fluid phase electrode lead
US6480737B1 (en) 1999-12-29 2002-11-12 Impulse Dynamics Nv Field delivery safety system using detection of atypical ECG
US20060085046A1 (en) 2000-01-20 2006-04-20 Ali Rezai Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system
US6600953B2 (en) 2000-12-11 2003-07-29 Impulse Dynamics N.V. Acute and chronic electrical signal therapy for obesity
US7096070B1 (en) 2000-02-09 2006-08-22 Transneuronix, Inc. Medical implant device for electrostimulation using discrete micro-electrodes
US7195637B2 (en) 2000-04-18 2007-03-27 Impulse Dynamics N.V. Method and device for inserting leads into coronary veins
US6754532B1 (en) 2000-04-28 2004-06-22 Medtronic, Inc. Coronary sinus flow regulated pacing
EP1284781B1 (en) 2000-05-04 2017-10-11 Impulse Dynamics N.V. Signal delivery through the right ventricular septum
US6712831B1 (en) 2000-06-16 2004-03-30 Aaron V. Kaplan Methods and apparatus for forming anastomotic sites
WO2005009250A1 (en) 2003-06-30 2005-02-03 Magenta Medical Corporation Methods and apparatus for forming anastomotic sites
US6694192B2 (en) 2000-07-06 2004-02-17 Impulse Dynamics N.V. Uterus muscle controller
US7499742B2 (en) 2001-09-26 2009-03-03 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US8086314B1 (en) 2000-09-27 2011-12-27 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US7623926B2 (en) 2000-09-27 2009-11-24 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6985774B2 (en) 2000-09-27 2006-01-10 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6850801B2 (en) 2001-09-26 2005-02-01 Cvrx, Inc. Mapping methods for cardiovascular reflex control devices
US7158832B2 (en) 2000-09-27 2007-01-02 Cvrx, Inc. Electrode designs and methods of use for cardiovascular reflex control devices
US7616997B2 (en) 2000-09-27 2009-11-10 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US6522926B1 (en) 2000-09-27 2003-02-18 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US6749600B1 (en) 2000-11-15 2004-06-15 Impulse Dynamics N.V. Braided splittable catheter sheath
US6564096B2 (en) 2001-02-28 2003-05-13 Robert A. Mest Method and system for treatment of tachycardia and fibrillation
US6684105B2 (en) 2001-08-31 2004-01-27 Biocontrol Medical, Ltd. Treatment of disorders by unidirectional nerve stimulation
US6748271B2 (en) 2001-07-27 2004-06-08 Cardiac Pacemakers, Inc. Method and system for treatment of neurocardiogenic syncope
US8934968B2 (en) 2001-08-03 2015-01-13 Cardiac Pacemakers, Inc. Neurostimulation and coronary artery disease treatment
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
US6845776B2 (en) 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20140046407A1 (en) 2001-08-31 2014-02-13 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
US7904176B2 (en) 2006-09-07 2011-03-08 Bio Control Medical (B.C.M.) Ltd. Techniques for reducing pain associated with nerve stimulation
US7778703B2 (en) 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Selective nerve fiber stimulation for treating heart conditions
US8615294B2 (en) 2008-08-13 2013-12-24 Bio Control Medical (B.C.M.) Ltd. Electrode devices for nerve stimulation and cardiac sensing
US7778711B2 (en) 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Reduction of heart rate variability by parasympathetic stimulation
US7974693B2 (en) 2001-08-31 2011-07-05 Bio Control Medical (B.C.M.) Ltd. Techniques for applying, configuring, and coordinating nerve fiber stimulation
US8571653B2 (en) 2001-08-31 2013-10-29 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
US7885709B2 (en) 2001-08-31 2011-02-08 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation for treating disorders
US8565896B2 (en) 2010-11-22 2013-10-22 Bio Control Medical (B.C.M.) Ltd. Electrode cuff with recesses
US20080119898A1 (en) 2005-09-22 2008-05-22 Biocontrol Medical Ltd. Nitric oxide synthase-affecting parasympathetic stimulation
US7308303B2 (en) 2001-11-01 2007-12-11 Advanced Bionics Corporation Thrombolysis and chronic anticoagulation therapy
US6669693B2 (en) 2001-11-13 2003-12-30 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US6746465B2 (en) * 2001-12-14 2004-06-08 The Regents Of The University Of California Catheter based balloon for therapy modification and positioning of tissue
US6741878B2 (en) 2001-12-14 2004-05-25 Biosense Webster, Inc. Basket catheter with improved expansion mechanism
US8233991B2 (en) 2002-02-04 2012-07-31 Boston Scientific Neuromodulation Corporation Method for programming implantable device
US20070135875A1 (en) * 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7146984B2 (en) 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US7386346B2 (en) 2002-04-22 2008-06-10 Medtronic, Inc. Controlled and modulated high power racing combined with intracardiac pressure monitoring feedback system utilizing the chronicle implantable hemodynamic monitoring (IHM) and calculated EPAD
US7862513B2 (en) 2002-05-14 2011-01-04 Pacesetter, Inc. Apparatus for minimally invasive calibration of implanted pressure transducers
US8204591B2 (en) 2002-05-23 2012-06-19 Bio Control Medical (B.C.M.) Ltd. Techniques for prevention of atrial fibrillation
US20140214135A1 (en) 2002-05-23 2014-07-31 Bio Control Medical (B.C.M.) Ltd. Dissolvable electrode device
US7321793B2 (en) 2003-06-13 2008-01-22 Biocontrol Medical Ltd. Vagal stimulation for atrial fibrillation therapy
US20120303080A1 (en) 2003-06-13 2012-11-29 Bio Control Medical (B.C.M.) Ltd. Parasympathetic nerve stimulation
US8036745B2 (en) 2004-06-10 2011-10-11 Bio Control Medical (B.C.M.) Ltd. Parasympathetic pacing therapy during and following a medical procedure, clinical trauma or pathology
US7277761B2 (en) 2002-06-12 2007-10-02 Pacesetter, Inc. Vagal stimulation for improving cardiac function in heart failure or CHF patients
US7904151B2 (en) 2002-07-24 2011-03-08 Bio Control Medical (B.C.M.) Ltd. Parasympathetic stimulation for treating ventricular arrhythmia
US6944490B1 (en) 2002-09-25 2005-09-13 Advanced Cardiovascular Systems, Inc. Apparatus and method for positioning and delivering a therapeutic tool to the inside of a heart
US7277757B2 (en) 2002-10-31 2007-10-02 Medtronic, Inc. Respiratory nerve stimulation
US6887266B2 (en) 2002-11-14 2005-05-03 Synecor, Llc Endoprostheses and methods of manufacture
US20040098090A1 (en) 2002-11-14 2004-05-20 Williams Michael S. Polymeric endoprosthesis and method of manufacture
US7285287B2 (en) 2002-11-14 2007-10-23 Synecor, Llc Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses
US20050187615A1 (en) 2004-02-23 2005-08-25 Williams Michael S. Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture
US7704276B2 (en) 2002-11-15 2010-04-27 Synecor, Llc Endoprostheses and methods of manufacture
US7163554B2 (en) 2002-11-15 2007-01-16 Synecor, Llc Endoprostheses and methods of manufacture
AU2003290698A1 (en) 2002-11-15 2004-06-15 Synecor, Llc Polymeric endoprosthesis and method of manufacture
US7555351B2 (en) 2002-12-19 2009-06-30 Cardiac Pacemakers, Inc. Pulmonary artery lead for atrial therapy and atrial pacing and sensing
US7857748B2 (en) 2003-01-15 2010-12-28 Syne Cor, Llc Photocurable endoprosthesis methods of manufacture
US7387629B2 (en) 2003-01-21 2008-06-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter design that facilitates positioning at tissue to be diagnosed or treated
US6885889B2 (en) 2003-02-28 2005-04-26 Medtronic, Inc. Method and apparatus for optimizing cardiac resynchronization therapy based on left ventricular acceleration
CN1787850B (en) 2003-03-10 2015-12-16 脉冲动力公司 For transmitting the signal of telecommunication to revise the apparatus and method of gene expression in heart tissue
US6932930B2 (en) 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
US7276062B2 (en) 2003-03-12 2007-10-02 Biosence Webster, Inc. Deflectable catheter with hinge
US7658709B2 (en) 2003-04-09 2010-02-09 Medtronic, Inc. Shape memory alloy actuators
US6832478B2 (en) 2003-04-09 2004-12-21 Medtronic, Inc. Shape memory alloy actuators
US20080046016A1 (en) 2003-05-23 2008-02-21 Biocontrol Medical Ltd. Intravascular parasympatheticstimulation for atrial cardioversion
US8060197B2 (en) 2003-05-23 2011-11-15 Bio Control Medical (B.C.M.) Ltd. Parasympathetic stimulation for termination of non-sinus atrial tachycardia
US8239045B2 (en) 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
US7082336B2 (en) 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
JP4616252B2 (en) 2003-06-04 2011-01-19 シネコー・エルエルシー Intravascular electrophysiology system and method
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
EP1648560A4 (en) 2003-06-13 2015-10-28 Biocontrol Medical Ltd Vagal stimulation for anti-embolic therapy
EP1648558A4 (en) 2003-06-13 2015-05-27 Biocontrol Medical B C M Ltd Applications of vagal stimulation
US7092759B2 (en) 2003-07-30 2006-08-15 Medtronic, Inc. Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion
AU2004285412A1 (en) 2003-09-12 2005-05-12 Minnow Medical, Llc Selectable eccentric remodeling and/or ablation of atherosclerotic material
US20050247320A1 (en) 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US7480532B2 (en) 2003-10-22 2009-01-20 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US20050119752A1 (en) 2003-11-19 2005-06-02 Synecor Llc Artificial intervertebral disc
US7377939B2 (en) 2003-11-19 2008-05-27 Synecor, Llc Highly convertible endolumenal prostheses and methods of manufacture
AU2004298995A1 (en) 2003-12-12 2005-06-30 Synecor, Llc. Implantable medical device having pre-implant exoskeleton
US8024050B2 (en) 2003-12-24 2011-09-20 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US7706884B2 (en) 2003-12-24 2010-04-27 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US20050149132A1 (en) 2003-12-24 2005-07-07 Imad Libbus Automatic baroreflex modulation based on cardiac activity
US7460906B2 (en) 2003-12-24 2008-12-02 Cardiac Pacemakers, Inc. Baroreflex stimulation to treat acute myocardial infarction
US8126559B2 (en) 2004-11-30 2012-02-28 Cardiac Pacemakers, Inc. Neural stimulation with avoidance of inappropriate stimulation
US7486991B2 (en) 2003-12-24 2009-02-03 Cardiac Pacemakers, Inc. Baroreflex modulation to gradually decrease blood pressure
US7643875B2 (en) 2003-12-24 2010-01-05 Cardiac Pacemakers, Inc. Baroreflex stimulation system to reduce hypertension
US20050273146A1 (en) 2003-12-24 2005-12-08 Synecor, Llc Liquid perfluoropolymers and medical applications incorporating same
US20050271794A1 (en) 2003-12-24 2005-12-08 Synecor, Llc Liquid perfluoropolymers and medical and cosmetic applications incorporating same
US7509166B2 (en) 2003-12-24 2009-03-24 Cardiac Pacemakers, Inc. Automatic baroreflex modulation responsive to adverse event
US7869881B2 (en) 2003-12-24 2011-01-11 Cardiac Pacemakers, Inc. Baroreflex stimulator with integrated pressure sensor
US20080015659A1 (en) 2003-12-24 2008-01-17 Yi Zhang Neurostimulation systems and methods for cardiac conditions
US20050142315A1 (en) 2003-12-24 2005-06-30 Desimone Joseph M. Liquid perfluoropolymers and medical applications incorporating same
US8126560B2 (en) 2003-12-24 2012-02-28 Cardiac Pacemakers, Inc. Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US7873413B2 (en) 2006-07-24 2011-01-18 Cardiac Pacemakers, Inc. Closed loop neural stimulation synchronized to cardiac cycles
US7295881B2 (en) 2003-12-29 2007-11-13 Biocontrol Medical Ltd. Nerve-branch-specific action-potential activation, inhibition, and monitoring
US7572228B2 (en) 2004-01-13 2009-08-11 Remon Medical Technologies Ltd Devices for fixing a sensor in a lumen
US7547286B2 (en) 2004-02-16 2009-06-16 Choate John I M Method to reduce inflammation and tactile finger sensation deficit due to carpal tunnel syndrome or arthritis
US20050187556A1 (en) 2004-02-25 2005-08-25 Synecor, Llc Universal percutaneous spinal access system
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
EP1750799A2 (en) 2004-05-04 2007-02-14 The Cleveland Clinic Foundation Methods of treating medical conditions by neuromodulation of the sympathetic nervous system
US8412348B2 (en) 2004-05-06 2013-04-02 Boston Scientific Neuromodulation Corporation Intravascular self-anchoring integrated tubular electrode body
US7260431B2 (en) 2004-05-20 2007-08-21 Cardiac Pacemakers, Inc. Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device
US8116881B2 (en) 2004-06-10 2012-02-14 Bio Control Medical (B.C.M.) Ltd Electrode assembly for nerve control
WO2006012050A2 (en) 2004-06-30 2006-02-02 Cvrx, Inc. Connection structures for extra-vascular electrode lead body
EP1804907A2 (en) 2004-09-10 2007-07-11 The Cleveland Clinic Foundation Methods and systems of achieving hemodynamic control through neuromodulation
JP2008514372A (en) 2004-09-30 2008-05-08 サインコア,リミテッド・ライアビリティ・カンパニー Artificial disc nucleus
US20060074453A1 (en) 2004-10-04 2006-04-06 Cvrx, Inc. Baroreflex activation and cardiac resychronization for heart failure treatment
US8175705B2 (en) 2004-10-12 2012-05-08 Cardiac Pacemakers, Inc. System and method for sustained baroreflex stimulation
US8244355B2 (en) 2004-10-29 2012-08-14 Medtronic, Inc. Method and apparatus to provide diagnostic index and therapy regulated by subject's autonomic nervous system
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7891085B1 (en) 2005-01-11 2011-02-22 Boston Scientific Neuromodulation Corporation Electrode array assembly and method of making same
US8609082B2 (en) 2005-01-25 2013-12-17 Bio Control Medical Ltd. Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
US8224444B2 (en) 2005-02-18 2012-07-17 Bio Control Medical (B.C.M.) Ltd. Intermittent electrical stimulation
US7769446B2 (en) 2005-03-11 2010-08-03 Cardiac Pacemakers, Inc. Neural stimulation system for cardiac fat pads
US7363082B2 (en) 2005-03-24 2008-04-22 Synecor Llc Flexible hermetic enclosure for implantable medical devices
US7542800B2 (en) 2005-04-05 2009-06-02 Cardiac Pacemakers, Inc. Method and apparatus for synchronizing neural stimulation to cardiac cycles
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7881782B2 (en) 2005-04-20 2011-02-01 Cardiac Pacemakers, Inc. Neural stimulation system to prevent simultaneous energy discharges
US7904158B2 (en) 2005-04-28 2011-03-08 Medtronic, Inc. Measurement of coronary sinus parameters to optimize left ventricular performance
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US7561923B2 (en) 2005-05-09 2009-07-14 Cardiac Pacemakers, Inc. Method and apparatus for controlling autonomic balance using neural stimulation
US7734348B2 (en) 2005-05-10 2010-06-08 Cardiac Pacemakers, Inc. System with left/right pulmonary artery electrodes
US7765000B2 (en) 2005-05-10 2010-07-27 Cardiac Pacemakers, Inc. Neural stimulation system with pulmonary artery lead
US7617003B2 (en) 2005-05-16 2009-11-10 Cardiac Pacemakers, Inc. System for selective activation of a nerve trunk using a transvascular reshaping lead
WO2007029254A2 (en) 2005-09-06 2007-03-15 Impulse Dynamics N.V. Apparatus and method for delivering electrical signals to a heart
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US7630760B2 (en) 2005-11-21 2009-12-08 Cardiac Pacemakers, Inc. Neural stimulation therapy system for atherosclerotic plaques
CA2637787A1 (en) 2006-02-03 2007-08-16 Synecor, Llc Intravascular device for neuromodulation
US8406864B2 (en) 2006-02-07 2013-03-26 Impulse Dynamics Nv Assessing cardiac activity
US8457763B2 (en) * 2006-04-27 2013-06-04 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US8005543B2 (en) 2006-05-08 2011-08-23 Cardiac Pacemakers, Inc. Heart failure management system
US7801604B2 (en) 2006-08-29 2010-09-21 Cardiac Pacemakers, Inc. Controlled titration of neurostimulation therapy
US8620422B2 (en) 2006-09-28 2013-12-31 Cvrx, Inc. Electrode array structures and methods of use for cardiovascular reflex control
US9643004B2 (en) * 2006-10-31 2017-05-09 Medtronic, Inc. Implantable medical elongated member with adhesive elements
US7805194B1 (en) 2006-11-03 2010-09-28 Pacesetter, Inc. Matrix optimization method of individually adapting therapy in an implantable cardiac therapy device
US8311633B2 (en) 2006-12-04 2012-11-13 Synecor Llc Intravascular implantable device having superior anchoring arrangement
WO2008070189A2 (en) 2006-12-06 2008-06-12 The Cleveland Clinic Foundation Method and system for treating acute heart failure by neuromodulation
US8005545B2 (en) 2007-01-24 2011-08-23 Bio Control Medical (B.C.M.) Ltd. Parasympathetic stimulation for prevention and treatment of atrial fibrillation
US8150521B2 (en) 2007-03-15 2012-04-03 Cvrx, Inc. Methods and devices for controlling battery life in an implantable pulse generator
US8406877B2 (en) 2007-03-19 2013-03-26 Cardiac Pacemakers, Inc. Selective nerve stimulation with optionally closed-loop capabilities
WO2008135985A1 (en) 2007-05-02 2008-11-13 Earlysense Ltd Monitoring, predicting and treating clinical episodes
US8081590B2 (en) 2007-05-02 2011-12-20 Synapse Wireless, Inc. Systems and methods for controlling sleep states of network nodes
US20090018596A1 (en) 2007-05-15 2009-01-15 Cvrx, Inc. Baroreflex activation therapy device with pacing cardiac electrical signal detection capability
US8901878B2 (en) 2007-06-05 2014-12-02 Impulse Dynamics Nv Transcutaneous charging device
US20090012542A1 (en) 2007-07-03 2009-01-08 Synecor, Llc Satiation devices and methods for controlling obesity
US20090012546A1 (en) 2007-07-03 2009-01-08 Synecor, Llc Devices for treating gastroesophageal reflux disease and hiatal hernia, and methods of treating gastroesophageal reflux disease and hiatal hernia using same
US8249717B2 (en) 2007-07-18 2012-08-21 Cardiac Pacemakers, Inc. Systems and methods for providing neural stimulation transitions
WO2009015081A2 (en) 2007-07-20 2009-01-29 Cvrx, Inc. Elective service indicator based on pulse count for implantable device
US7676266B1 (en) 2007-07-30 2010-03-09 Pacesetter, Inc. Monitoring ventricular synchrony
US8060218B2 (en) 2007-08-02 2011-11-15 Synecor, Llc Inductive element for intravascular implantable devices
US8027724B2 (en) 2007-08-03 2011-09-27 Cardiac Pacemakers, Inc. Hypertension diagnosis and therapy using pressure sensor
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8204596B2 (en) 2007-10-31 2012-06-19 Synecor Llc Isolation connector for an intravascular implantable medical device
US8527064B2 (en) 2007-12-12 2013-09-03 Cardiac Pacemakers, Inc. System for stimulating autonomic targets from pulmonary artery
US8155744B2 (en) 2007-12-13 2012-04-10 The Cleveland Clinic Foundation Neuromodulatory methods for treating pulmonary disorders
US8216225B2 (en) 2007-12-21 2012-07-10 St. Jude Medical, Atrial Fibrillation Division, Inc. Irrigated ablation electrode assembly having a polygonal electrode
US20150151121A1 (en) 2008-01-31 2015-06-04 Enopace Biomedical Ltd. Enhancing perfusion by contraction
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
US20140114377A1 (en) 2008-01-31 2014-04-24 Enopace Biomedical Ltd. Vagus nerve stimulation
US9005106B2 (en) 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8626299B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US7925352B2 (en) 2008-03-27 2011-04-12 Synecor Llc System and method for transvascularly stimulating contents of the carotid sheath
WO2009135083A1 (en) 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US8103360B2 (en) * 2008-05-09 2012-01-24 Foster Arthur J Medical lead coil conductor with spacer element
US8239037B2 (en) 2008-07-06 2012-08-07 Synecor Llc Intravascular implant anchors having remote communication and/or battery recharging capabilities
CN102143780B (en) 2008-07-08 2014-03-12 心脏起搏器股份公司 Systems for delivering vagal nerve stimulation
JP5300982B2 (en) 2008-10-10 2013-09-25 カーディアック ペースメイカーズ, インコーポレイテッド Multi-sensor system for managing heart failure patients
US8386053B2 (en) 2008-10-31 2013-02-26 Medtronic, Inc. Subclavian ansae stimulation
US8706230B2 (en) 2009-04-23 2014-04-22 Impulse Dynamics Nv Implantable lead connector
US20110066017A1 (en) 2009-09-11 2011-03-17 Medtronic, Inc. Method and apparatus for post-shock evaluation using tissue oxygenation measurements
US8412326B2 (en) 2009-10-30 2013-04-02 Cardiac Pacemakers, Inc. Pacemaker with vagal surge monitoring and response
JP6013186B2 (en) 2009-11-13 2016-10-25 セント ジュード メディカル インコーポレイテッド Staggered arrangement of shochu elements
US8249706B2 (en) 2010-01-26 2012-08-21 Pacesetter, Inc. Adaptive rate programming control in implantable medical devices using ventricular-arterial coupling surrogates
US9050453B2 (en) * 2010-03-19 2015-06-09 National Cerebral And Cardiovascular Center Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefore
EP2558160B1 (en) 2010-04-15 2021-11-17 Cardiac Pacemakers, Inc. Autonomic modulation using transient response with intermittent neural stimulation
US9408661B2 (en) * 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US20130018444A1 (en) 2011-07-11 2013-01-17 Glenn Richard A Intravascular electrodes for transvascular stimulation
WO2012149511A2 (en) 2011-04-28 2012-11-01 Synecor Llc Neuromodulation systems and methods for treating acute heart failure syndromes
US20150150508A1 (en) 2010-08-31 2015-06-04 Interventional Autonomics Corporation Intravascular electrodes and anchoring devices for transvascular stimulation
US8934956B2 (en) 2010-08-31 2015-01-13 Interventional Autonomics Corporation Intravascular electrodes and anchoring devices for transvascular stimulation
US8452406B2 (en) 2010-09-15 2013-05-28 Cardiac Pacemakers, Inc. Automatic selection of lead configuration for a neural stimulation lead
WO2012058692A2 (en) 2010-10-29 2012-05-03 Cvrx, Inc. Implant tool and improved electrode design for minimally invasive procedure
WO2012068273A1 (en) 2010-11-16 2012-05-24 Tva Medical, Inc. Devices and methods for forming a fistula
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8983601B2 (en) 2011-02-25 2015-03-17 The Cleveland Clinic Foundation Extravascular neuromodulation to treat heart failure
US20120232563A1 (en) 2011-03-08 2012-09-13 Medtronic, Inc. Implant catheters for physiological pacing
WO2013003368A1 (en) 2011-06-28 2013-01-03 Boston Scientific Neuromodulation Corporation System and method for using impedance to determine proximity and orientation of segmented electrodes
US9446240B2 (en) 2011-07-11 2016-09-20 Interventional Autonomics Corporation System and method for neuromodulation
US9067071B2 (en) 2011-07-11 2015-06-30 Interventional Autonomics Corporation System and method for neuromodulation
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
CA2848781C (en) * 2011-09-19 2018-10-23 Boston Scientific Scimed, Inc. Subintimal re-entry catheter and retrograde recanalization
EP2779929A1 (en) 2011-11-15 2014-09-24 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
CN104066395B (en) 2011-12-15 2017-09-05 里兰斯坦福初级大学理事会 Apparatus and method for treating pulmonary hypertension
US8825130B2 (en) 2011-12-30 2014-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode support structure assemblies
US20140074148A1 (en) 2012-02-21 2014-03-13 Synecor Llc Embolic protection system and method for use in an aortic arch
US20130289686A1 (en) 2012-04-29 2013-10-31 Synecor Llc Intravascular electrode arrays for neuromodulation
CN104470579B (en) 2012-06-06 2018-06-01 洋红医疗有限公司 Artificial kidney valve
WO2014007871A1 (en) 2012-07-05 2014-01-09 Mc10, Inc. Catheter device including flow sensing
EP2887890A4 (en) 2012-08-23 2016-05-18 Minimally Invasive Surgical Access Ltd Direct aortic access system for transcatheter aortic valve procedures
WO2014032038A1 (en) 2012-08-24 2014-02-27 Synecor Llc System for facilitating transcatheter aortic valve procedures using femoral access
US9833608B2 (en) 2012-11-20 2017-12-05 NeuroTronik IP Holding (Jersey) Limited Positioning methods for intravascular electrode arrays for neuromodulation
US9446243B2 (en) 2012-12-07 2016-09-20 Boston Scientific Neuromodulation Corporation Patient posture determination and stimulation program adjustment in an implantable stimulator device using impedance fingerprinting
US9656089B2 (en) 2012-12-14 2017-05-23 Boston Scientific Neuromodulation Corporation Method for automation of therapy-based programming in a tissue stimulator user interface
EP2968916B1 (en) 2013-03-12 2021-05-19 Cardiac Pacemakers, Inc. Medical device with multiple sensor fusion
EP3653113B1 (en) 2013-03-13 2022-05-04 Magenta Medical Ltd. Impeller with hollow central lumen
US9494960B2 (en) 2013-03-14 2016-11-15 Boston Scientific Neuromodulation Corporation Voltage regulator programmable as a function of load current
CN105339038B (en) 2013-06-18 2017-08-18 心脏起搏器股份公司 System and method for mapping pressoreceptor
EP3057488B1 (en) 2013-10-14 2018-05-16 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
EP3077044B1 (en) 2013-12-05 2018-08-29 Cardiac Pacemakers, Inc. System for dosed delivery of autonomic modulation therapy
US9764113B2 (en) 2013-12-11 2017-09-19 Magenta Medical Ltd Curved catheter
WO2015138360A1 (en) 2014-03-09 2015-09-17 Neuro Tronik Ip Holding (Jersey) Limited Systems and methods for neuromodulation of sympathetic and parasympathetic cardiac nerves
US9415224B2 (en) 2014-04-25 2016-08-16 Cyberonics, Inc. Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction
US9597515B2 (en) 2014-03-28 2017-03-21 Cardiac Pacemakers, Inc. Systems and methods for facilitating selection of one or more vectors in a medical device
SG10201808553QA (en) 2014-05-22 2018-11-29 Cardionomic Inc Catheter and catheter system for electrical neuromodulation
JP2017522923A (en) 2014-06-03 2017-08-17 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Electrode assembly with atraumatic distal tip
US9848795B2 (en) 2014-06-04 2017-12-26 Boston Scientific Scimed Inc. Electrode assembly
US20170312525A1 (en) 2014-08-06 2017-11-02 NeuroTronik IP Holding (Jersey) Limited Systems and methods for neuromodulation of sympathetic and parasympathetic cardiac nerves
AU2015315570B2 (en) 2014-09-08 2020-05-14 CARDIONOMIC, Inc. Methods for electrical neuromodulation of the heart
US20160174864A1 (en) 2014-12-18 2016-06-23 Biosense Webster (Israel) Ltd. Far Field-Insensitive Intracardiac Catheter Electrodes
US10493278B2 (en) 2015-01-05 2019-12-03 CARDIONOMIC, Inc. Cardiac modulation facilitation methods and systems
WO2016123161A1 (en) 2015-01-30 2016-08-04 Cardiac Pacemakers, Inc. Physiologic event detection and data storage
WO2016176333A1 (en) 2015-04-27 2016-11-03 Reflex Medical, Inc. Systems and mehtods for sympathetic cardiopulmonary neuromodulation
US20170065818A1 (en) 2015-09-08 2017-03-09 Interventional Autonomics Corporation Neuromodulation Systems and Methods for Treating Acute Heart Failure Syndromes
JP2019513032A (en) 2016-03-09 2019-05-23 カーディオノミック,インク. Cardiac contraction stimulation system and method
US11026619B2 (en) 2016-04-13 2021-06-08 Cardiac Pacemakers, Inc. Determining cardiac pacing capture effectiveness of an implantable medical device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6532388B1 (en) * 1996-04-30 2003-03-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US8204606B2 (en) * 2002-12-19 2012-06-19 Cardiac Pacemakers, Inc. Implantable lead for septal placement of pacing electrodes
US20120330092A1 (en) * 2011-06-23 2012-12-27 Akira Shiose Device, system, and method for modulating cardiac function
US20130072995A1 (en) * 2011-07-11 2013-03-21 Terrance Ransbury Catheter system for acute neuromodulation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11806159B2 (en) 2016-03-09 2023-11-07 CARDIONOMIC, Inc. Differential on and off durations for neurostimulation devices and methods
US11559687B2 (en) 2017-09-13 2023-01-24 CARDIONOMIC, Inc. Methods for detecting catheter movement
US11648395B2 (en) 2018-08-13 2023-05-16 CARDIONOMIC, Inc. Electrode assemblies for neuromodulation
US11607176B2 (en) 2019-05-06 2023-03-21 CARDIONOMIC, Inc. Systems and methods for denoising physiological signals during electrical neuromodulation

Also Published As

Publication number Publication date
EP3194007B1 (en) 2018-07-04
AU2015315658A1 (en) 2017-04-06
US20170173338A1 (en) 2017-06-22
AU2015315658B2 (en) 2019-05-23
CA2957791A1 (en) 2016-03-17
US10894160B2 (en) 2021-01-19
EP3194007A1 (en) 2017-07-26
WO2016040037A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
US20200197692A1 (en) Catheter and catheter system for electrical neuromodulation
US20210370068A1 (en) Floatable catheters for neuromodulation
US11806159B2 (en) Differential on and off durations for neurostimulation devices and methods
AU2020217387B2 (en) Methods for electrical neuromodulation of the heart
EP3242717B1 (en) Cardiac modulation facilitation systems
US20240130671A1 (en) Neurostimulation devices and methods

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: CARDIONOMIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WALDHAUSER, STEVEN L.;GOEDEKE, STEVEN D.;FRION, DUANE G.;REEL/FRAME:058340/0212

Effective date: 20160125

STPP Information on status: patent application and granting procedure in general

Free format text: PRE-INTERVIEW COMMUNICATION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION